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1 ABSTRACT 
 
Aneuploidy is a change in number or structure of one or more chromosomes that are not 
a multiple of the whole chromosome set. One of the best known pathological 
aneuploidies is trisomy 21 (Down syndrome), with chromosome 21 present in three 
instead of two copies. Patients with Down syndrome display severe mental retardation 
and growth defects. In fact, most abnormal aneuploid karyotypes lead to spontaneous 
abortions during embryogenesis, indicating that aneuploidy is not well tolerated in 
humans. Aneuploidy was also shown to be a common hallmark of cancer tissues; 
however, the debate is ongoing whether aneuploidy is rather a by-product or a trigger of 
tumorigenesis. Even though aneuploid karyotypes were already identified more than 100 
years ago little is understood about cellular physiology of aneuploidy cells, especially in 
humans. To uncover the consequences of numerical aneuploidy in human cells, I 
generated aneuploid cell lines derived from the human cell lines HCT116 and RPE-1 
hTERT. First, we showed that aneuploid cells proliferate slower compared to their 
disomic counterparts. A detailed cell cycle analysis revealed that this delay was due to a 
prolonged G1 and S phase, whereas G2 and M phase remained unperturbed. 
Furthermore, we conducted an in depth genome wide comparison of DNA, mRNA and 
protein levels in aneuploid cells. Using CGH, mRNA array and SILAC technology, we 
quantified the changes in DNA, mRNA and protein abundance. We revealed that extra 
chromosomes are actively transcribed and translated. However, the abundance of some 
proteins, particularly subunits of protein complexes and protein kinases, are adjusted 
towards disomic levels. Additionally, we asked how the cellular physiology is affected by 
the addition of a specific chromosome. Two scenarios are possible: either the cellular 
response depends on the additional chromosomes or all aneuploid cells show the same 
changes of cellular physiology. Indeed, we found that all aneuploid cell lines show similar 
physiological responses, irrespective of the type of additional chromosome. All aneuploid 
cell lines down-regulate DNA and RNA metabolism and up-regulate among others 
energy metabolism, lysosome function and membrane biosynthesis pathways. 
Lysosomes which are involved in autophagy are besides the ubiquitin-proteasome 
system important for cellular protein turn over. We found p62-dependent selective 
autophagy increased in all analyzed cell lines with extra chromosomes suggesting a role 
of p62-dependent selective autophagy in maintenance of protein homeostasis upon 
expression of extra protein in these cell lines. 
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2 INTRODUCTION 
 
Passing hereditary information faithfully from mother to daughter cell is crucial for all 
living organisms. Before each cell division, cells duplicate their hereditary information, 
which is then later equally distributed onto the daughter cells, thus generating two cells 
with exactly the same genetic information. Eukaryotes store their hereditary information 
on separate chromosomes within their nuclei. Diploid organisms contain two of each 
chromosome type (2N) (Fig. 1). A normal human cell exhibits 23 pairs of chromosomes, 
22 pairs of autosomes with identical genetic information and one pair of heterosomes. 
The heterosome pairs, XX and XY, determine the sex, whereas the autosomes are 
present equally in males and females. In comparison to diploids, haploid cells contain 
only one set of chromosomes (1N). Genome integrity is maintained by checkpoints which 
ensure the generation of two daughter cells with identical genetic material. 
 
2.1 Chromosomal abnormalities 
Numerical or structural changes of chromosomes can result from errors during 
amplification and segregation of the hereditary information. Depending on the type of 
error cells with aberrant chromosome content are either aneuploid or polyploid.  
Polyploidy describes a chromosome content which is a multiple of the parental euploid 
karyotype. There are different types of polyploidy, such as triploid cells containing three 
or tetraploids containing four chromosome sets. Even though tetraploidy leads to death in 
early developmental stages during embyrogenesis (Kaufman 1991) polyploidy is a 
common phenomenon in nature. As polyploid plants and their fruits are bigger in size 
generation of a polyploid karyotype is used for breeding (e.g. wheat and banana)(Elliott 
1958). Furthermore, polyploidy is common in many human tissues and organs, as for 
example tetraploid hepatocytes (Guidotti, Bregerie et al. 2003), polyploid 
megakaryocytes (Raslova, Roy et al. 2003) and embryonic polyploid trophoblasts (Sarto, 
Cominato et al. 1982). However, the function of polyploidy in these tissues remains 
unclear.  
In contrast, aneuploidy is a change in number or structure of chromosomes that are not a 
multiple of the whole chromosome set. Aneuploidy can arise by chromosome non-
disjunction either after mitotic division of cells or after meiosis leading to aneuploid 
gametes. Fusion of an aneuploid gamete with a normal haploid gamete can lead to the 
offspring of an aneuploid embryo. One of the best known embryonic aneuploidies is 
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trisomy 21 (Down syndrome), with chromosome 21 present in three instead of two copies 
(Fig. 1). Embryos with Down syndrome display severe growth defects. Other identified 
viable aneuploid disorders are trisomy 13 and 18. No other aneuploid disorders were 
found to be compatible with live and most aneuploidies affecting the whole organism are 
lethal. In fact, most spontaneous abortions are due to an abnormal aneuploid karyotype 
(Toikkanen, Joensuu et al. 1993). Likewise, trisomic mice die during embryogenesis and 
the only viable trisomy is trisomy 19, leading to death shortly after birth (Magnuson, 
Smith et al. 1982). Accordingly, aneuploidy in flies (Lindsley, Sandler et al. 1972) and 
nematodes leads to developmental defects and lethality (Hodgkin, Horvitz et al. 1979).  
 
  
 
Fig. 1: Human diploid (A) and aneuploid trisomy 21 (B) karyotype. In diploid cells, all 23 
chromosomes are present in two copies (2N), except the heterosomes in males (A). Aneuploid cells 
display a karyotype with a change in number or structure of single or multiple chromosomes that are 
not a multiple of the whole chromosome set. Trisomy 21 patients display a karyotype with three copies  
of chromosome 21 (marked in red) instead of two (B). 
 
However, aneuploid cells can also arise during cell division of somatic cells. Aneuploidy 
was shown to be a common hallmark of cancer. In fact, 90% of solid tumors are 
aneuploid (Storchova and Kuffer 2008). In 2007, Yuorov and colleagues found that 30-
35% of all brain cells in healthy humans are aneuploid, but it is not known whether these 
cells are able to propagate. Interestingly, an increased frequency of aneuploid cells was 
found in brains of Alzheimer´s disease patients. The exact function of aneuploid cells in 
human brains remains unclear (Yurov, Iourov et al. 2007) (Yurov, Vorsanova et al. 2009).  
It is important to separate aneuploidy from chromosomal instability (CIN) which is as well 
as aneuploidy a frequent hallmark of cancer (Holland and Cleveland 2009). Whereas 
aneuploidy describes the present state of the genomic material, chromosomal instability 
describes ongoing missegregation of different chromosomes (Holland and Cleveland 
2009). Therefore, chromosomally unstable cells are always aneuploid as e.g. shown in 
cancerous tissues (Nagaoka, Hassold et al. 2012) whereas aneuploid cells are not 
always chromosomally unstable, as shown in cells from Down syndrome patients. 
A B 
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2.2 Origins of aneuploidy 
Whole chromosome aneuploidies result from chromosome segregation errors. 
Chromosome missegregation can either happen randomly or due to mutations leading to 
defects in spindle assembly checkpoint (SAC), sister chromatid cohesion or merotelic 
attachment (Fig. 2). In contrast to whole chromosome aneuploidies structural 
aneuploidies can result from errors in DNA replication and repair. These currently known 
mechanisms of aneuploidization in somatic cells are summarized in the following 
paragraphs.  
The SAC is a checkpoint that creates a wait signal during mitosis until the kinetochores of 
all chromosomes are properly attached to microtubules. Even one kinetochore that is not 
attached to a microtubule is sufficient to trigger the SAC signal (Rieder, Cole et al. 1995). 
A complete knockout of many spindle checkpoint genes such as genes encoding for 
Bub3 and Mad2 were shown to be embryonic lethal (Dobles, Liberal et al. 2000; Kalitsis, 
Earle et al. 2000). However, mice with impaired SAC survive and their cells can divide 
even though the chromosomes are not aligned properly leading to chromosomally 
instable cells (Fig. 2A). This was shown by Michel and colleagues who generated Mad2 
haplo-insufficient mice which developed lung tumors at high rates and respective cells 
displayed high levels of chromosomally instable aneuploid cells (Michel, Liberal et al. 
2001). Similarly, mice heterozygous for Bub1, BubR1 and Bub3 develop high levels of 
aneuploidies and spontaneous or induced tumor development (Dai, Wang et al. 2004; 
Baker, Jeganathan et al. 2006; Jeganathan, Malureanu et al. 2007).  
A second mechanism which defect results in chromosomal missegregation, is sister 
chromatid cohesion. Two newly replicated sister chromatids are kept together by 
evolutionary conserved protein complexes called cohesins. This protects the sisters 
chromatids from premature segregation, which may result in aneuploidy (Fig. 2B). The 
cohesin rings are cleaved by separase at anaphase onset. Sister chromatid cohesion is 
necessary to create tension by keeping the sister chromatids together while the 
microtubules attached to the kinetochores pull them apart (Peters 2012). Aneuploidy was 
found to be increased in yeast cells with defects in proteins involved in chromatid 
cohesion (Guacci, Koshland et al. 1997; Michaelis, Ciosk et al. 1997). In concordance, it 
was shown that inactivation of STAG2, a subunit of the cohesion complex, leads to 
aneuploidy in human cells (Solomon, Kim et al. 2011). Moreover, a recent screen 
sequenced somatic mutations of chromosomally instable colorectal cancer cell lines. 
Intriguingly, authors revealed that identified mutated genes coded for yeast homologues 
that were found to regulate sister chromatid cohesion (Barber, McManus et al. 2008). In 
line, separase levels were found to be increased in breast cancer tissues (Zhang, Ge et 
al. 2008) and STAG2 levels were decreased in human cancer cell lines, indicating an in 
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vivo role of cohesion in tumorigenesis. Moreover, age dependent defects of cohesion 
during oogenesis in elderly women were found to increase levels of aneuploid oocytes 
resulting in higher levels of aneuploid embryos (Lister, Kouznetsova et al. 2010). 
Furthermore, it was shown that sister chromatid cohesion is important to prevent 
merotelic attachment (Cimini 2008).  
 
  
 
 
Fig. 2: Origins of whole chromosome aneuploidies. Chromosome missegregation can lead to whole 
chromosome aneuploidy. Three known mechanisms can lead to chromosome missegregation. Spindle assembly 
checkpoint defects (A), Cohesion defects (B) and merotelic attachment (C+D). Merotelic attachment can either 
arise randomly (C) or is happening more frequently in cells with multiple centrosomes. These cells either display a 
multiploar divion and die in most of the cases or are able to cluster their centrosomes, which then tend to merotelic 
attachment (D). Figure adapted from: (Holland and Cleveland 2009) 
 
Merotelic attachment classifies the attachment of one sister chromatid to microtubules 
from both spindle poles. Besides resulting from chromatid cohesion defects merotelic 
attachment can also arise spontaneously. In many cases this type of error is not 
recognized by the SAC, because both kinetochores are attached to microtubules under 
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sufficient tension. Therefore, merotelic attachment remains often uncorrected.  
Attachment defects result in lagging chromosomes (chromosomes that are not properly 
aligned) and consequently chromosome missegregation and aneuploidy (Fig. 2C) 
(Cimini, Howell et al. 2001). Recently, it was shown that cells with multiple centrosomes 
tend to missegregate their chromosomes due to a high frequency of merotelic attachment 
(Ganem, Godinho et al. 2009). Authors propose that chromosomes connect to 
microtubules from two different spindle poles during an intermediate multipolar stage 
during cell division. Then multiploarity is resolved to bypolarity by clustering of 
centrosomes and merotelic attachment leads to chromosome missegregation. This 
explains why cells with multiple centrosomes are usually highly chromosomally instable 
(Sato, Mizumoto et al. 2001; Lingle, Barrett et al. 2002). This finding is in contrast to the 
long standing hypothesis that cells with multiple centrosomes become aneuploid due to 
multipolar division by distributing the chromosomes on more than two daughter cells 
(Holland and Cleveland 2009). Since Ganem and colleagues could show that cells 
derived from multipolar division undergo apoptosis (Ganem, Godinho et al. 2009) 
generation of aneuploidy is probably rather due to merotelic attachment (Fig. 3D). It was 
proposed that aneuploidy results out of tetraploidy as tetraploid cells are chromosomally 
instable and loose chromosomes over time (Mayer and Aguilera 1990; Fujiwara, Bandi et 
al. 2005). Interestingly, tetraploid cells with doubled centrosome number passing 
intermediate stages of multiploarity were shown to have elevated levels of lagging 
chromosomes which were not detectable in tetraploid cells with only two centrosomes 
(Ganem, Godinho et al. 2009).  
Many aneuploid cells do not display numerical aneuploidies but structural aneuploidies. 
The origin of these gross chromosomal rearrangements (GCRs) in aneuploid cells is 
mostly unclear. It is known that DNA damaging agents such as γ-irradiation and 
hydroxyurea induce chromosomal rearrangements (Suzuki, Ojima et al. 2003) suggesting 
that rearrangements might be a result of improper repair of DNA lesions. Defects such as 
mutations or deletions of proteins involved in homologous recombination leads to 
genomic instability as well. Moreover, perturbations of DNA replication results in elevated 
levels of chromosomal rearrangements (Huang and Koshland 2003). Lagging 
chromosomes often form micronuclei after cell division. Replication of this trapped DNA 
is often defective and results in a pulverization of the chromosome which is later 
reassembled leading to structural aneuploidy (Crasta, Ganem et al. 2012).  
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2.3 Aneuploidy and gene expression levels  
The hallmark of aneuploidy is an altered karyotype with either amplified or deleted 
genome regions if compared to euploidy. The question arises whether changes in gene 
copy number lead to a proportional scaling of expression-levels. Transgene experiments 
adding single genes to a cell provide evidence that at least for single genes protein levels 
scale according to gene copy number (reviewed in (Birchler 2010)).  
First studies in aneuploid plants showed expression levels of most transcripts do not 
scale according to gene copy number (Guo and Birchler 1994). Whereas, studies of 
aneuploid yeast and mouse cells showed mRNA are transcribed in a dosage dependent 
manner (Amano, Sago et al. 2004; Upender, Habermann et al. 2004; Torres, Sokolsky et 
al. 2007; Williams, Prabhu et al. 2008). How transcriptional levels are changed in 
aneuploid cells was also addressed by scientists studying dosage compensation of sex 
chromosomes. Dosage compensation describes a mechanism compensating gene 
expression dosage of sex chromosomes to maintain equal gene expression levels in 
male and female organisms (Zhang and Oliver 2007). In mammals, females are able to 
inactivate randomly one of their X chromosomes by methylation of DNA and histones to 
compensate the extra load of gene numbers in comparison to males. In contrast, gene 
expression levels of the X chromosome in male fruit fly are up-scaled. Gene expression 
levels in male Drosophila are maintained by the male-specific lethal (MSL) complex. The 
complex contains MOF, an acetyltransferase, which is believed to activate gene 
expression by acetylating histone H4 at lysine 16 (Akhtar and Becker 2000).  Dosage 
compensation is achieved at transcriptional levels and not post translationally (Belote and 
Lucchesi 1980). Similar compensation mechanisms could also influence gene expression 
patterns of different gene copy numbers in aneuploid cells. To address this possibility, 
Zhang and colleagues performed a genome wide transcriptome analysis of Drosophila 
S2 cells containing segmental aneuploidies, comparing gene expression levels to gene 
copy number. Interestingly, they found that transcripts of aneuploid gene regions are 
dosage compensated and that this dosage compensation on mRNA level is not 
dependent on the MSL complex (Zhang, Malone et al.). Differences in gene expression 
studies can be various and variations observed between mammals and flies are probably 
rather due to evolutionary divergence and therefore are probably due to different 
strategies how organisms cope with their extra load of genetic material.  
Most studies analyzed transcriptional levels in aneuploids. However, buffering 
mechanisms for subunit proteins of macromolecular complexes in aneuploid maize and 
flies were described already more than 30 years ago (Birchler and Newton 1981; Devlin, 
Holm et al. 1982). In line, two studies in aneuploid yeast showed that even though 
transcripts were present according to the gene copy number some proteins were at 
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levels as expected for euploid cells. Accordingly, 20% of proteins did not scale 
proportionally with their gene copy number, but were present at lower levels. Intriguingly, 
all compensated proteins identified, are subunits of protein complexes (Torres, Sokolsky 
et al. 2007; Torres, Dephoure et al. 2010). However, another study analyzing aneuploid 
yeast with complex karyotypes found no significant compensation of a specific protein 
group (Pavelka, Rancati et al. 2010), which may be due to differences in karyotype 
complexity. The reason why some proteins do not scale according to gene copy number 
remains unknown. Three reasons may lead to this protein compensation. Subunits of 
protein complexes may not be translated into proteins, are less stable or are actively 
degraded. Data by Torres and colleagues as described above suggests that aneuploid 
yeast require proteasomal degradation to proliferate as well as haploid yeast (Torres, 
Dephoure et al. 2010), indicating that subunits may be actively degraded. 
In conclusion, aneuploid cells show most studies showed that transcriptional levels scale 
with gene copy number. It was suggested that specific proteins such as subunits of 
macromolecular complexes are compensated to a level lower as expected for gene copy 
number. However, detailed studies on protein levels especially in human aneuploid cells 
are missing.  
 
2.4 Cell proliferation and physiology of aneuploids  
Most whole embryo aneuploidies in humans lead to miscarriages and viable aneuploid 
humans display mental retardation and growth defects. In line with these findings, 
cultured fibroblasts derived from Down syndrome patients grow slower in comparison to 
diploid fibroblasts (Segal and McCoy 1974). Similarly, aneuploid MEF and artificially 
generated aneuploid yeast cells grow significantly slower compared to their non-
aneuploid counterparts (Torres, Sokolsky et al. 2007; Williams, Prabhu et al. 2008; 
Pavelka, Rancati et al. 2010).  
Pathway analyses were performed to gain first insights into how aneuploidy affects 
cellular physiology. There are two possibilities how extra protein could influence cellular 
physiology. First, depending on the set of altered proteins distinct cellular pathways could 
be influenced. Amplification of a chromosome containing e.g. a negative regulator of a 
pathway could lead to an inhibitory effect of this pathway due to its increased expression. 
This would mean that a specific loss or gain of a chromosome with its specific genes 
would lead to a distinct de-regulated pathway pattern which should be different in every 
individual aneuploidy. Second, aneuploid cells could also show similar cellular physiology 
independent of the type of extra chromosome. This may be the case if cellular physiology 
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is rather altered by common characteristics of aneuploid cells such as protein stress.  
Detailed studies on deregulated pathways in aneuploid cells were performed so far only 
in yeast (Torres, Sokolsky et al. 2007; Pavelka, Rancati et al. 2010). Whereas Pavelka et 
al. could not find a common pattern of pathway regulation in aneuploid yeast Torres et al. 
observed a transcriptional regulation pattern similar to the environmental stress response 
(ESR). The effect of aneuploidy on cellular physiology was also tested in transformed as 
well as cancerous human cell lines which contained a transferred chromosome. Multiple 
transcripts were deregulated across the whole genome however, no common aneuploidy 
specific pathway pattern was reported (Upender, Habermann et al. 2004). Similarly, 
studies in Drosophila cells did not reveal any aneuploidy specific response (Zhang, 
Malone et al. ; Stenberg, Lundberg et al. 2009). In contrast it was just recently published 
that aneuploid yeast (single chromosome aneuploidies as well as complex aneuploidies), 
plant, mice and human cells show highly related gene expression patterns (Sheltzer, 
Torres et al. 2012), indicating that differences in most studies are probably due to 
differences in data analysis. However, fly cells may have alternate mechanisms how to 
deal with aneuploidy.   
There is indication, that aneuploid yeasts have an altered energy metabolism which may 
cause reduced growth rates. Aneuploid yeast showed down-regulation of proteins 
involved in energy metabolism under growth limiting conditions. Moreover, aneuploid 
yeast assimilates higher levels of glucose and creates less biomass per glucose 
compared to wild-type yeast. In line, two gene loci of the two glucose transporters, Hxt6 
and Hxt7 were amplified, confirming that aneuploid yeast needs more glucose for survival 
(Torres, Sokolsky et al. 2007). On the other hand, aneuploid MEF cells showed no 
significant increase in glucose uptake, but instead lactate uptake was elevated in 
comparison to disomic MEFs. Additionally, glutamine consumption was significantly 
increased as well as ammonium production (Williams, Prabhu et al. 2008). However, why 
cells show these differences in metabolite production and consumption remains unclear 
but there are hypothesis that transcription, translation and degradation of protein 
encoded on the extra chromosome require energy, which leads to an increased need for 
energy metabolites (Williams, Prabhu et al. 2008). 
Further studies were conducted to test if either DNA or mRNA and protein affect cellular 
growth. First, extra DNA was added to haploid yeast cells using a yeast artificial 
chromosome (YAC) containing non-transcribed human and mouse DNA. Cells 
harbouring these YACs showed no growth delay, indicating that growth defects are due 
to changed mRNA or protein abundance (Torres, Sokolsky et al. 2007) and not to the 
additional DNA. To test if proteins are harmful to aneuploid cells same authors treated 
cells with drugs affecting protein homeostasis. Indeed, they could show that aneuploid 
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cells are more sensitive to several drugs such as cycloheximide, thioloutin, hygromycin, 
rapamycin, geldanamycin and MG132. Moreover, aneuploid yeast cells were more 
sensitive to higher temperatures. All these treatments affect cellular protein homeostasis. 
Cycloheximide, hygromycin as well as rapamycin inhibit protein synthesis. Geldanamyin 
inhibits Hsp90, an important chaperone that is actively transcribed after heatshock, 
whereas increased temperature triggers the heat shock response. MG132 inhibits the 
proteasome and sensitivity suggests an important function of the proteasome in 
aneuploid yeast. Accordingly, a recent study indicates that increased proteasome activity 
allows aneuploid yeast cells to grow faster. Aneuploid yeast was showed improved 
growth-rates upon several gene-deletions, including UBP6, which encodes a de-
ubiquitinating enzyme (Torres, Dephoure et al. 2010). Authors speculate that deletion 
leads to a higher turnover of protein by the proteasome (Torres, Dephoure et al. 2010) 
and therefore, a relief of the protein burden on cellular physiology. Taken together, data 
suggests that aneuploid cells are indeed challenged with protein stress, which is probably 
due to the extra protein expressed in aneuploid cells. However, why most of these drugs 
affect aneuploid cell proliferation remains unknown. 
In contrast to these studies, Pavelka and colleagues could not show a common 
sensitivity of aneuploid yeast cells towards certain drugs (Pavelka, Rancati et al. 2010). 
Authors studied proliferation capacity of aneuploid yeasts under various drug treatments 
such as drugs used as chemotherapeutics or antifungal drugs. Here aneuploid strains 
show a high diversity of sensitivity towards various drugs which was dependend on the 
type of extra chromosomes. Whereas some of the aneuploid strains grew worse, other 
aneuploid strains displayed growth benefits compared to their euploid counterpart when 
treated with some drugs, such as rapamycin, bleomycin and thiolutin. Rapamycin as well 
as thiolutin however, had anti-proliferative effects in the study conducted by Torres and 
colleagues. Differences between these two studies may result from differences in 
complexity of aneuploidy. Pavelka and collegues used yeast with complex aneuploid 
karyotype ranging between 1N and 3N whereas Torres et al added single chromosomes 
to haploid yeast. The study by Pavelka and colleagues indicates that altered gene 
expression may lead to phenotypic variation. Therefore, a complex aneuploid karyotype 
could lead to an evolutionary advantage of cells towards specific stresses. Evolutionary 
aspects of this study are further discussed in the chapter “Aneuploidy and tumorigenesis” 
The first study in mammalian cells revealed three drugs, AICAR, chloroquinee and 17-
AAG affecting growth of aneuploid MEF cells as well as aneuploid cancer cell lines 
(Tang, Williams et al. 2011). As described above, yeast aneuploid cells seem to have an 
altered energy metabolism, which would be in line with the sensitivity to AICAR, a drug 
which activates AMPK and induces energy stress (Corton, Gillespie et al. 1995). 
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Moreover, aneuploid yeasts were shown to be more sensitive to the inhibition of Hsp90 
by geldanamycin. In accordance, this mammalian cell study shows that inhibition of 
Hsp90 by 17-AAG, a derivative of geldanamycin, affects growth of aneuploid cells, 
However, geldanamycin itself was not tested. In contrast to aneuploid yeast cells. 
mammalian cells were sensitive to chloroquinee. Chloroquinee is an anti-malarian drug 
which was shown to inhibit autophagy. However, aneuploid yeast cells were shown to be 
sensitive to MG132, a proteasome inhibitor. This indicates that aneuploid yeast and 
mammalian cells require different protein degradation pathways for proliferation. Besides 
these three drugs a series of drugs was tested inducing genotoxic, proteotoxic as well as 
energy stress. Intriguingly, most protein stress inducing drugs did not affect growth of 
aneuploid cells, therefore, being not as striking as in the yeast study. Differences 
between studies in mammalian and yeast cells may be due to differences in protein 
homeostasis. Mammalian cells may have alternative pathways to bypass the inhibtion of 
another one.  
In conclusion, there is indication that aneuploid cells display a common aneuploidy 
specific cellular response, which may be conserved. Furthermore, aneuploid cells display 
marked growth defects, which are probably based on an increased need in energy due to 
transcription, translation and degradation of extra protein. However, this hypothesis is 
mainly based on correlative studies and detailed experiments elucidating underlying 
mechanisms are yet missing.  
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2.5 Aneuploidy and tumorigenesis 
Even though, aneuploidy was found to be a hallmark of cancerous tissues already 100 
years ago (Boveri 1912) the relationship between aneuploidy and tumorigenesis remains 
elusive. Since mice with high level of chromosome missegregation develop cancer with 
high frequency, it is hypothesized that aneuploidy can trigger tumor formation. Multiple 
observations made in the last century indicate that there is a relationship between 
aneuploidy and tumorigenesis.  
 
 
Fig. 3: Aneuploidy and tetraploidy in human cancers. Displayed are karyotypes as listed in the 
Mittelman database, sorted by cancer types. The graph clearly shows that multiple cancer types contain 
high level of aneuploidies. Highest peaks are found around diploidy (46 chromosomes), likely 
indicating missegeration events. In some of the cancer types, karyotypes vary below tetraploidy (92 
chromosomes). Figure adapted from (Storchova and Kuffer 2008). 
 
As shown in Fig. 3, karyotyping of multiple human tumors showed that cancer tissues 
contain a highly variable chromosome content, ranging from hypertetraploidy (more than 
the doubled chromosome number) to hypodiploidy (chromosome number less than 
diploid karyotype), with an accumulation of cells with a karyotype ranging around diploidy 
and tetraploidy (Mittelman data base), (Storchova and Kuffer 2008). Tumor cells of some 
tissues seem to propagate the aberrant karyotype stably whereas others tumor cells are 
chromosomally instable resulting in tissues containing cells with various karyotypes 
(Lengauer, Kinzler et al. 1997).  
Moreover, the oncogene c-MYC (chromosome 8) is often amplified in various cancer 
types (Escot, Theillet et al. 1986; Nesbit, Tersak et al. 1999) and accordingly, 
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chromosome 8 amplification is one of the most frequent aneuploidies (10-20%) found in 
acute myeloid leukaemia (AML) (Paulsson and Johansson 2007). A recent study on 
somatic copy number alterations in cancer showed that 25% of cancer cells display either 
whole arm or whole chromosome aneuploidies, whereas only 10% of cells contain small, 
site specific changes, so called focal SCNAs (Beroukhim, Mermel et al. 2010). As 
described above, changes in the levels or function of spindle assembly checkpoint (SAC) 
proteins is a possible mechanism for chromosome missegeregation and thus can lead to 
aneuploidy. Interestingly, defects in the SAC, such as low BUB1 levels were observed in 
several colorectal cancer cell lines (Cahill, Lengauer et al. 1998). Jeganathan and 
colleagues (Jeganathan, Malureanu et al. 2007) generated mice expressing reduced 
levels of BUB1. These mice develop spontaneous tumors with a high level of aneuploidy. 
MEF cells isolated from the mutant mice exhibit high rates of chromosome 
missegregation. Similarly, mice heterozygous for Mad2, BubR1 and Bub3 are prone to 
spontaneous or induced tumor development (Dai, Wang et al. 2004; Baker, Jeganathan 
et al. 2006). Furthermore, MAD2 overexpression is a common phenomenon in human 
tumors (Sotillo, Hernando et al. 2007) and leads to chromosomal instability (Hernando, 
Nahle et al. 2004). It was shown that overexpression of MAD2 leads to aneuploidy as a 
consequence from a checkpoint override and promotes tumorigenesis in mice (Sotillo, 
Hernando et al. 2007), Weaver and colleagues have shown that Cenp-E+/- mice 
developed high levels of tumors with an aneuploid phenotype (Weaver and Cleveland 
2007; Weaver, Silk et al. 2007). Athough these data support the hypothesis that 
aneuploidy leads to tumorigenesis, it remains unclear whether the cancer phenotypes 
observed in these mice models are due to the aneuploidy or due to another unknown 
functions of the spindle assembly checkpoint proteins. Another study performed in 2005 
by Fujiwara and colleagues could show that injection of p53-/- tetraploid cells into mice 
lead to a high frequency of malignant mammary epithelial cancers. Moreover, tumors 
tissues were highly aneuploid (Fujiwara, Bandi et al. 2005). Since, tetraploidy presents a 
rather instable state (Storchova and Pellman 2004) it is not surprising that these 
developing tumors were aneuploid. In contrast to other studies, this study indicates that 
aneuploidy itself can lead to cancer formation. In conclusion, many studies suggest a role 
of aneuploidy in tumorigenesis. However, if aneuploidy triggers  
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2.6 Aneuploidy and chromosomal instability 
It was proposed that numerical aneuploidy leads to increased chromosomal instability. A 
recent study showed that aneuploid yeasts indeed display an increased level of 
chromosome missegregation, DNA damage and mitotic recombination in comparison to 
haploid yeasts (Sheltzer, Blank et al. 2011). Moreover, it was shown that chromosomal 
instability is dependent on the type of aneuploidy. Therefore, chromosomal instability was 
relatively low if aneuploidy was close to haploidy. However, the closer the aneuploid 
karyotype was to the 2N state, the more increased their level of chromosomal instability 
(Zhu, Pavelka et al. 2012). Inherent instability of aneuploid may provide an explanation 
how aneuploidy could trigger tumor formation. Intriguingly, chromosomal instability was 
shown to lead to a poor prognosis and high level of resistance to chemotherapeutics 
(Gao, Furge et al. 2007; Choi, Seo et al. 2009). Additionally, as aneuploid yeasts were 
shown to be less chromosomally stable than haploids they may adapt easier to various 
stresses due to higher genomic variability. This is in line with studies by Pavelka and 
colleagues who found that aneuploid yeast displayed growth advantages compared to 
their euploid counterparts if treated with certain drugs (Pavelka, Rancati et al. 2010). 
Since aneuploid yeasts used in this study were naturally generated and contain more 
complex aneuploidies, one could speculate that evolutionary progress could already take 
place during generation of aneuploid strains. Besides aneuploid cells may evolve due to 
external stresses, they may also evolve to internal factors (e.g. the reason for their slow 
growth). As another study showed that after cultivation of aneuploid yeast, some yeast 
strains were able to improve their growth to a similar level as their euploid counterpart. 
After analysis of these fast growing aneuploid yeast strains authors identified multiple 
changes and most often a deletion of the gene encoding for Ubp6, a de-ubiquitinating 
enzyme. Authors hypothesize that deletion of UBP6 leads to a higher turnover of protein 
by the proteasome. This increased protein degradation abolishes the burden of extra 
protein on the cell and enables increased growth (Torres, Dephoure et al. 2010). 
Therefore, after cultivation of aneuploid yeast, cells displayed genomic changes that 
were shown to be beneficial for their growth. Accordingly, also aneuploid MEF cells were 
able to immortalize faster than normal diploid MEFs (Williams, Prabhu et al. 2008). 
Immortalization results from mutations and modulations of genes leading to increased 
proliferation rate. Therefore, increased immortalization rate may be due to a higher level 
of chromosomal instability as observed for aneuploid yeast.  
In conclusion, aneuploid yeast cells were shown to display increased chromosomal 
instability. This may allow aneuploid cells to adapt faster to certain stresses than their 
euploid counterparts, providing an interesting evolutionary model. In line, increased 
chromosomal instability of aneuploid cells could also explain how aneuploidy leads to 
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tumorigenesis. However, reasons for increased chromosomal instability and DNA 
damage in aneuploid cells remain elusive and further research is needed to dissect the 
underlying molecular mechanisms. 
 
2.7 Protein stress  
Current research indicates that aneuploid cells suffer from protein overexpression due to 
their extra genetic material. A surplus of proteins can be harmful to a cell due to several 
reasons. Overexpression of proteins can lead to protein missfolding and aggregation 
which can be harmful for cellular homeostasis. Proteins with long hydrophobic chains can 
interfere with protein function of other proteins and aggregate, which in turn can lead to 
the disruption of important cellular functions (Chiti, Stefani et al. 2003; Stefani and 
Dobson 2003). Missfolding of a single protein can lead to the destabilization of other 
proteins and thus start a reaction that may have detrimental effects for a cell (Gidalevitz, 
Ben-Zvi et al. 2006; Gidalevitz, Krupinski et al. 2009). The hallmark of several 
neurodegenerative diseases such as Parkinson’s, Huntigton’s and Alzheimer’s disease is 
an accumulation of aggregating proteins (Bossy-Wetzel, Schwarzenbacher et al. 2004). 
Why these protein aggregates are toxic to the cell is not yet completely understood. 
Olzscha and colleagues showed that artificially constructed amyloids promoted 
interactions and sequestered other cellular proteins that were large in size and rich in 
unstructured regions. Most of these proteins that were sequestered with the artificially 
constructed amyloids have important functions and authors hypothesize that aggregation 
of these proteins may lead to the proteotoxicity and disruption of important cellular 
functions (Olzscha, Schermann et al.). Protein aggregation diseases usually affect 
neurons indicating that neurons are more prone to accumulate missfolded proteins 
(Drummond and Wilke 2008). Aggregation diseases occur in aging organisms because 
orchestration of proteostasis decreases with age (Balch, Morimoto et al. 2008) resulting 
from the decreasing function of protein degradation and folding machinery (Sherman and 
Goldberg 2001; Morimoto 2008). Moreover, proteotoxicity was recently hypothesized to 
play a role in aging since pathways that prevent proteotoxicity were found to be important 
for longevity in C. elegans (Taylor and Dillin 2011). 
To avoid proteotoxic effects, cells developed sophisticated regulatory mechanisms 
controlling protein translation, folding, segregation and degradation (Balch, Morimoto et 
al. 2008). The rate of protein translation as the first step of protein quality control can be 
adapted by multiple means and affect proteins either globally or specifically (Gebauer 
and Hentze 2004). Reducing the translational rate could provide more time for protein 
folding and degradation and therefore affect protein homeostasis. Some proteins fold 
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spontaneously after translation, whereas others need to be folded by chaperones 
(Morimoto 2008). Upon thermal shock all cells from prokaryotes to eukaryotes react by 
overexpressing heat shock proteins (HSPs), which are chaperones that enable the cell to 
refold missfolded proteins (Ellis, van der Vies et al. 1989) (Lindquist and Craig 1988; 
Morimoto 2008). There are several different heat shock proteins that are classified by 
their molecular weight, such as Hsp90 and Hsp70. The main regulators of the heat shock 
response are transcription factors (HSFs) that allow expression of heat shock response 
proteins (Akerfelt, Morimoto et al. ; Morimoto 2008). Some cellular proteins are translated 
by ribosomes associated with endoplasmic reticulum (ER) and translocated into the ER 
lumen, where they are folded. The ER contains chaperones to fold proteins within the 
ER. Faulty protein folding in the ER triggers a stress response pathway called the 
unfolded protein response (UPR) (Schroder and Kaufman 2005; Walter and Ron 2011). 
Only correctly folded proteins are transported to their final destination by the ER. If a 
protein remains missfolded it is delivered to the proteasome and degraded via ER 
associated degradation (ERAD) (Hurtley, Bole et al. 1989; Ellgaard and Helenius 2003). 
Cells usually undergo apoptosis after persistent ER stress (Tabas and Ron 2011). Thus, 
maintenance of correct protein levels and folding is essential for the cells and old, 
aberrant or malfunctional proteins as well as proteins that remain missfolded despite the 
above mentioned protein quality control system must be degraded. This is achieved by 
the two major protein degradation machineries, the ubiquitin-proteasome-system (UPS) 
and autophagy (Ciechanover 2005). 
 
2.8 Protein degradation  
2.8.1 Proteasomal degradation  
One of the best studied protein degradation machineries is the ubiquitin-proteasome-
system (UPS). Degradation of proteins via the UPS is a tightly regulated process that is 
carried out in several steps. High selectivity is maintained by tagging substrates with 
ubiquitin, which marks them for the degradation by the 26S proteasome (Hochstrasser 
1996; Hershko and Ciechanover 1998). Ubiquitin, as the name indicates, is ubiquitously 
expressed and highly conserved among eukaryotes. It is a globular 76 amino acid 
protein, which can be covalently attached to a lysine (K) of the target protein via its C-
terminus. Ubiquitination involves an enzymatic E1-E2-E3 cascade (Fig. 4). Initially, an 
ubiquitin activating enzyme (E1) enzyme forms a high energy thioester with ubiquitin’s C-
terminus in an ATP dependent reaction. The ubiquitin moiety is subsequently transferred 
to the active cysteine of an ubiquitin conjugating enzyme (E2). Finally, ubiquitin is 
conjugated to the ε-amino group of a lysine residue in the substrate protein. This step is 
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catalyzed by ubiquitin ligases (E3) (Hershko and Ciechanover 1998; Glickman and 
Ciechanover 2002). 
Substrates can undergo several rounds of ubiquitination, resulting in the formation of 
ubiquitin chains. Depending on the lysine residues in ubiquitin used for conjugation, 
chains with several linkage types and therefore topologies can be formed.  The type of 
ubiquitin modification results in diverse biological outcomes. K48-linked polyubiquitin 
chains for example target proteins for degradation via the 26S proteasome (Hicke and 
Dunn 2003), whereas monoubiquitination can regulate the substrate activity, and K63-
linked chains mediate processes in transcription (Muratani and Tansey 2003), DNA 
repair (Hoege, Pfander et al. 2002) and endocytosis (Hicke and Dunn 2003). 
Ubiquitiniation is a reversible process. Ubiquitin deconjugation is performed by de-
ubiquitinating enzymes (DUBs) (Amerik and Hochstrasser 2004; Nijman, Luna-Vargas et 
al. 2005).  
 
Fig. 4: The ubiquitin 
conjugation pathway.  
Ubiquitin is activated in an 
energy dependent step by the 
enzyme E1, involving an 
AMP-ubiquitin intermediate. 
Ubiquitin is then transferred to 
the cystein of an E2. The E3 
ligase catalyzes finally the 
conjugation of ubiquitin to the 
substrate. The E3 ligase can 
also conjugate the ubiquitin to 
another ubiquitin, thereby 
forming ubiquitin chains. 
Polyubiquitylated substrates 
are recognized and degraded 
by the 26S proteasome. 
Ubiquitination can be reversed 
by de-ubiquitinating enzymes 
(DUBs). Figure adapted from 
(Hochstrasser 2009). 
 
Substrates modified with K48-linked polyubiquitin chains are recognized by the 26S 
proteasome. The 26S proteasome consists of two subassemblies, the 20S core particle 
and the 19S regulatory particle. The 20S core particle is barrel shaped and consists of 
four rings, two outer α-rings and two inner β-rings, which themselves consist of seven 
subunits. The inner β-rings contain the active sites. The 19S regulatory particle 
recognizes ubiquitinated substrates via several ubiquitin binding domains, resulting in 
their unfolding and translocation into the 20S core particle. To mediate these tasks, the 
19S regulatory particle requires energy, which is provided by its six ATPase subunits. 
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After the cleavage of the substrate, the proteasome releases the resulting peptides as 
well as free ubiquitin, which can later be reused (Glickman and Ciechanover 2002).  
 
2.8.2 Autophagic degradation 
As the Greek name indicates, autophagy (”selfeating”) is a catabolic process that 
mediates degradation of proteins or organelles by the lysosome (Mizushima and Levine), 
(Yang and Klionsky). Most cells display basic levels of autophagy that can be further 
activated by several conditions such as starvation. Under starvation conditions, cells 
degrade old proteins to provide amino acids for new protein synthesis. Therefore, 
autophagy acts as a recycling process to maintain cellular physiology. Autophagy 
research was initially uncovered in budding yeast and multiple autophagy-related (ATG) 
genes were identified (Klionsky, Cregg et al. 2003). Autophagy research in mammalian 
cells becomes more and more popular as autophagy plays numerous functions in cell 
physiology and pathology. Three different classes of autophagy are currently known: 
chaperone-mediated autophagy, microautophagy and macroautophagy, the latter being 
best studied.  
Chaperone-mediated autophagy (Fig. 5A) is a process that enables degradation of 
specific proteins by sequestering them directly into the lysosome. Only proteins 
containing a KFERQ-sequence can be recognized and targeted by this pathway (Dice 
2007), (Orenstein and Cuervo)(Kaushik, Bandyopadhyay et al.). The cytosolic chaperone 
Hsc70 (heat shock cognate 70) recognizes the KFERQ-sequence (Chiang, Terlecky et 
al. 1989) and targets the substrates to the receptor Lamp2a which is located at the 
lysosomal membrane (Cuervo and Dice 1996) where the substrate is transported into the 
lysosome after unfolding (Salvador, Aguado et al. 2000). Chaperone-mediated 
autophagy was shown to be most active after oxidative stress (Kiffin, Christian et al. 
2004) or upon starvation. Only long starvation phases from more than 10 hours (Backer 
and Dice 1986) to 3 days (Cuervo, Knecht et al. 1995)  induce chaperone mediated 
autophagy. 
Microautophagy (Fig. 5B) engulfs proteins by invagination of the lysosomal membrane. 
Details are so far poorly understood and not further discussed here.  
Macroautophagy (Fig. 5C), hereafter referred to as autophagy, is the best studied 
lysosomal degradation process. Target proteins are engulfed by a double layered 
membrane called the autophagosome and transferred to the lysosome. During the 
transfer, autophagosome and lysosome fuse to form the autolysosome and the proteins 
are released for degradation. Despite intense research in the last years, the exact 
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orchestration of proteins and their functions remain to be resolved. In the following 
paragraphs I will focus on the autophagic machinery in mammalian cells.  
 
 
 
Fig. 5: Autophagy in mammalian cells. Depicted are the three known forms of autophagy: 
Chaperone-mediated autophagy (A), Microautophagy (B) and Macroautophagy (C). During chaperone-
mediated autophagy, Hsc70 is targeting proteins via the KFERQ-motif; the target proteins are 
transferred into the lysosome by Lamp2a mediated transport. During microautopagy, the lysosomal 
membrane directly engulfs proteins. Macroautophagy requires the formation of an autophagosome that 
collects proteins and/or organelles and releases them into the lysosome by fusion. Proteins are degraded 
by lysosomal hydrolases and permeases. Figure adapted from (Mizushima, Levine et al. 2008). 
 
 
2.8.2.1 The autophagy machinery  
The induction of autophagy is mediated by the ULK1-kinase, which acts downstream of 
TOR complex1 (TORC1) that negatively regulates autophagy (Mizushima). ULK1 is in a 
complex with mATG13 and FIP200 (an orthologue of yeast Atg17), which are both 
essential for autophagy. During activation of autophag, e.g. under starvation, suppression 
of mTORC1 causes dephosphorylation of ULK1, which is needed to activate autophagy 
(Jung, Jun et al. 2009)(Hosokawa, Hara et al. 2009). Membrane nucleation is the initial 
step of autophagy that enables autophagosome assembly. The origin of the double 
layered membrane remains unresolved however, there is evidence that it is derived from 
the ER membrane (Hayashi-Nishino, Fujita et al. 2009)(Yla-Anttila, Vihinen et al. 2009). 
Three class III PtdIns3K complexes are known to be involved in the formation of 
autophagosomes, the ATG14L complex (Matsunaga, Saitoh et al. 2009), the UVRAG 
complex (Itakura, Kishi et al. 2008) and the negatively regulating Rubicon complex 
(Matsunaga, Saitoh et al. 2009), each of the complexes containing hVSP34 and Beclin1 
(homologue of yeast Atg6). To form an autophagosome, the double layered membrane 
B
A 
C 
 2 INTRODUCTION  
20 
 
needs to grow to a vesicle. In this elongation step, two ubiquitin-conjugating-like systems 
are essential. The ubiquitin-like modifier ATG12 is activated by the E1-like enzyme 
ATG7, transferred to ATG10, which is an E2-ligase and conjugated to ATG5 (Mizushima, 
Sugita et al. 1998)(Yang and Klionsky). LC3 is an ubiquitin-like protein and required for 
the formation of the autophagosome. LC3 is synthesized as pro-LC3 and cleaved to LC3-
I by ATG4B. Then, LC3-I is activated by ATG7 and transferred to the E2-ligase ATG3, 
which conjugates LC3-I to phosphatidylethanolamine (PE) (Tanida, Tanida-Miyake et al. 
2002)(Tanida, Tanida-Miyake et al. 2001). The LC3-PE conjugate, also named LC3-II,is 
localized in the autophagosomal membrane. The two distinct forms of LC3 (LC3-I and 
LC3-II) are commonly used as autophagic markers (Klionsky, Abeliovich et al. 2008). 
Subsequently, the autophagosome and the lysosome fuse with each other to release 
proteins for degradation. This process requires the protein RAB7 (Gutierrez, Munafo et 
al. 2004). The protein FYCO1 recognizes RAB7, binds to LC3 and facilitates microtubule 
plus end-directed vesicle transport (Pankiv, Alemu et al. 2010). The fusion process is 
positively regulated by the UVRAG complex. Finally, after fusion, inner membrane LC3-II 
as well as other proteins are degraded by the lysosomal hydrolases whereas  the outer 
membrane LC3 gets recycled (Tanida, Ueno et al. 2008).  
 
2.8.2.2 Selective autophagy 
Macroautophagy was for a long time believed to degrade long lived and bulk proteins 
non-specifically. However, recent research revealed that autophagy can target specific 
proteins, or even aggregates (aggrephagy), pathogens (xenophagy) and organelles such 
as mitochondria (mitophagy) and peroxisome (pexophagy) (Xie and Klionsky 
2007)(Johansen and Lamark). In the recent years, receptors were identified that interact 
with cellular cargo to target it for degradation. The characteristics of all so far identified 
receptors are: interaction with LC3 by the LC3-interacting region (LIR domain), the ability 
to aggregate, and the ability to specifically recognize their substrates. The best 
characterized receptor for selective autophagy is p62/SQSTM1, hereafter referred to as 
p62. As other receptors, p62 can bind to LC3 via its LIR domain, which is a 22 amino 
acid long, linear motif (Pankiv, Clausen et al. 2007). Another important domain for its 
function is the ubiquitin binding UBA domain, which enables binding to ubiquitinated 
proteins. p62 can bind to ubiquitin chains with a preference for K63-linked ubiquitin 
chains (Long, Gallagher et al. 2008; Kirkin, McEwan et al. 2009). It was shown that only 
mono-ubiquitination of normally long-lived cytoplasmic proteins is sufficient to trigger 
degradation by autophagy (Kim, Hailey et al. 2008). The “Phox and Bem1p domain” 
(=PB1 domain) of p62 promotes oligomerization and probably aggregation, therefore 
allowing the formation of aggregates with its target proteins (Lamark, Perander et al. 
2003)(Kirkin, McEwan et al. 2009). As already mentioned above, p62 can target and 
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resolve protein aggregates (Bjorkoy, Lamark et al. 2005)(Komatsu, Waguri et al. 2007), 
(Pankiv, Clausen et al. 2007) and it colocalizes with ubiquitin positive foci in 
neurodegenerative disease tissues (Kuusisto, Salminen et al. 2002)(Kuusisto, Salminen 
et al. 2001). Thus, p62-histochemistry has been proposed as a marker for several 
aggregation diseases (Kuusisto, Kauppinen et al. 2008). Accordingly, autophagy deficient 
mice lacking ATG5 and ATG7 displayed signs of neurodegenerative diseases and 
accumulated ubiquitin positive inclusion bodies in neurons and hepatocytes without an 
expression of aberrant proteins that are known to form aggregates (Komatsu, Waguri et 
al. 2006)(Hara, Nakamura et al. 2006). Early studies of p62 deficient mice showed that 
they are prone to develop high levels of diabetes and obesity (Rodriguez, Duran et al. 
2006) but no signs for neurodegenerative diseases as found for ATG5 and ATG7. This 
was also confirmed by Komatsu and colleagues, who could not find any ubiquitin positive 
inclusion bodies neither in liver nor in brain tissue after genetic ablation of p62 (Komatsu, 
Waguri et al. 2007), which could be explained by loss of aggregation capacity that is 
mediated by the PB1 domain of p62. However, in p62 double knockout mice, brain cells 
show phenotypes of Alzheimer diseased brain with increase in K63-linked ubiquitin 
depending on age (Wooten, Geetha et al. 2008). This observation could also be 
explained by another protein that takes over the function of p62 in p62 deficient cells, 
such as NBR1, which was found to have similar functions (Kirkin, Lamark et al. 2009). 
Besides p62 other receptors were identified that target cellular material to the 
autophagosome, such as NBR1 (Kirkin, Lamark et al. 2009), HDAC6 (Iwata, Riley et al. 
2005) and NIX, that was shown to target mitochondria (Novak, Kirkin et al.). So far the 
field of selective autophagy research is just arising. Elucidating selected targets of these 
autophagy receptors remains an interesting field of research.  
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Aneuploidy is detrimental in human embryos and was shown to be a common 
hallmark of cancerous tissues. So far little is known how aneuploidy affects 
pathological phenotypes. Therefore, gaining insights on cellular physiology of 
aneuploid cells may be useful for understanding the phenotypes of aneuploidy linked 
diseases and for providing new strategies for drug development.  
Aneuploidy leads to growth defects as shown for cells isolated from trisomy 21 
patients, aneuploid mice and aneuploid yeasts. Furthermore, it was shown that in 
aneuploid mammalian cells transcripts scale proportionally to gene copy number, 
therefore transcribing the additional information from the extra chromosome. 
However, so far only little is known about how protein levels scale in aneuploid 
human cells.  
In this study my aim was first, to generate and characterize human cell lines with one 
or two extra chromosomes derived from the cell lines HCT116 and RPE-1 hTERT. 
Then we planned to evaluate growth characteristics of these generated tri- and 
tetrasomic cell lines and pinpoint their growth delay to a specific cell cycle phase. 
Finally, our aim was to compare DNA, mRNA and protein levels in direct comparison 
to each other. Therefore, I performed a quantitative analysis of DNA, mRNA and 
protein abundance changes using aCGH, mRNA array and SILAC technology. 
Thanks to the progress of large scale proteomics analysis in the recent years, we 
were able to compare whole genome wide protein levels of aneuploid cell lines to 
their disomic counterpart and between different aneuploid cell lines. We were 
interested whether protein levels scale proportionally with gene copy number, or 
whether we can find regulations for specific groups of proteins as suggested for 
yeast, plant and fly. Furthermore, we asked if tri- or tetrasomic cell lines show a 
distinct cellular response to the extra chromosome. 
Determination of pathways that are deregulated in all aneuploid cells will lead to 
further research analyzing how aneuploid cells differ from diploids. Identifying these 
differences is crucial for understanding the impact of aneuploidy on cellular 
physiology.  
.   
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Recent research showed that transcripts of yeast, mouse and human aneuploid cells 
scale according to gene copy number (Mao, Zielke et al. 2003; Amano, Sago et al. 2004; 
Torres, Sokolsky et al. 2007; Williams, Prabhu et al. 2008; Ried, Hu et al. 2012). 
However, not much is known about how protein levels are altered in human cells with an 
extra chromosome. To analyze protein expression levels and altered cellular physiology 
of aneuploid cells, cell lines were generated by adding extra chromosomes to the cell 
lines HCT116 and RPE-1 hTERT (hereafter referred to as RPE-1). This way we were 
able to construct cognate cell lines with an extra chromosome, which can be accurately 
compared to their parental cell lines.  
 
4.1 Construction of aneuploid cell lines  
Cell lines were constructed by adding an extra chromosome to chromosomally stable cell 
lines. To study the effect of an extra chromosome on cellular physiology it is important to 
carefully choose the parental cell lines since cell lines should be diploid and segregate 
their chromosomes faithfully. As recipient cell lines the cell line HCT116 and RPE-1 
hTERT (hereafter referred to as RPE-1) were employed. Both cell lines are frequently 
used for genome instability research due to their genome stability and near diploid 
karyotype. Aneuploid cell lines were generated by microcell fusion technique (Fournier 
1981) as described in Material and Methods. Cells were treated with antibiotics to select 
for aneuploid cells. Cell colonies arising after cultivation were expanded, collected and 
characterized by aCGH and chromosome paints analysis.  
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4.2 Description and characterization of cell lines 
4.2.1 HCT116 cell lines  
One cell line which was used to generate aneuploid cells was HCT116. HCT116 is a 
male, colorectal cancer cell line (ATCC), displaying a high frequency of microsatellite 
instability (MIN) but low levels of chromosomal instability (CIN) (Lengauer, Kinzler et al. 
1997). Cell lines with the addition of chromosome 3 and chromosome 5 were constructed 
by microcell fusion and were kindly provided by M. Koi (Koi, Umar et al. 1994; Haugen, 
Goel et al. 2008). To track cells for cell cycle studies, our laboratory (Christian Kuffer) 
created a stable HCT116 cell line with GFP-tagged histone 2B (H2B) (hereafter referred 
to as HCT116 H2B-GFP). To this cell line, chromosome 5 was added by using microcell 
fusion technique to generate HCT116 H2B-GFP cell lines with an extra chromosome. 
 
4.2.1.1 Verification of aneuploid karyotype by M-FISH and paints analysis 
The aneuploid karyotype of all created cell lines was verified by paints analyses and for 
HCT116 with extra chromosome 5 also by Multiplex-FISH (M-FISH). To confirm the 
successful chromosome transfer, the extra chromosome and one control chromosome of 
mitotic spreads were stained using paints probes, with DAPI counterstaining of all 
chromosomes (Fig. 6A). Furthermore, the exact karyotype of the HCT116 cell line with 
extra chromosome 5 and its parental HCT116 cell line was determined by detailed M-
FISH analysis which was performed by Chrombios GmbH (Fig. 7B). The cell line HCT116 
with extra chromosome 5 was used for detailed proteome analysis.  
Paints analysis revealed that the cell line with the added chromosome 3 contains one 
additional copy of chromosome 3 (hereafter referred to as HCT116 3/3), whereas the cell 
line with added chromosome 5 contains two additional copies of chromosome 5 
(hereafter referred to as HCT116 5/4). A part of chromosome 5 is translocated to another 
chromosome, which was present in all analyzed cells. Two different cell line types were 
generated for the cell line HCT116 H2B-GFP with added chromosome 5, one with one 
additional chromosome 5 (hereafter referred to as HCT116 H2B-GFP 5/3) and one with 
two additional chromosomes 5 (hereafter referred to as HCT116 H2B-GFP 5/4). The 
original HCT116 cell line was described to display the karyotype: 45,X,-­‐
Y,dup(10)(q24q26),der(16)t(8;16)q13;p13),der(18)t(17;18)(q21;p11.3) (Masramon, Ribas 
et al. 2000). M-FISH analysis confirmed the translocation for chromosome 8 to 
chromosome 16, as well as the translocation from chromosome 17 to 18 in HCT116 as 
well as HCT116 5/4 cell lines. Moreover, analysis confirmed the two extra copies of 
chromosome 5 in HCT116 5/4 and the chromosome which contains the translocated part 
of chromosome 5 was clearly identified as chromosome 16. For each cell line 10 
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karyograms were evaluated by Chrombios GmbH. One representative karyogram is 
shown in Fig 6B. To summarize, paints as well as M-FISH analyses confirmed the 
successful transfer of chromosomes to HCT116 derived cell lines and the generation of 
aneuploid cell lines.  
A 
 
 
B 
 
Fig. 6: Chromosome paint and M-FISH analysis. (A) Chromosome paint analysis of cell lines. Chromosome 5 
is depicted in red and chromosome 2 or 3 in green. The HCT116 cell line with the extra chromosome 3 contains 
one additional chromosome (HCT116 3/3). The cell line with chromosome 5 contains two extra copies (HCT116 
5/4). Two cell lines derived from HCT116 H2B-GFP were generated, one with one (HCT116 H2B-GFP 5/3) and 
one with two (HCT116 H2B-GFP 5/4) copies of chromosome 5. As expected, HCT116 and HCT116 H2B-GFP 
cell lines contain only two copies of every stained chromosome. (B) M-FISH analysis of HCT116 and HCT116 
5/4. The M-FISH karyograms of both cell lines are identical except for the extra chromosomes 5. A part of 
chromosome 5 is translocated to chromosome 16. This translocation is also visible in the paints analysis. 
 
4.2.1.2 Verification of DNA levels in aneuploid cells by aCGH analysis 
The generated cell lines might have gained aberrations that are not seen by mere 
staining of the extra chromosome. To further characterize created cell lines, genomic 
profiles of all cell lines were examined by 4x44 K aCGH analysis performed by IMGM 
laboratories (Fig. 7). aCGH analysis confirmed the amplifications observed by M-FISH 
analysis. These changes are also present in all analyzed HCT116 cell lines. Only the cell 
line HCT116 5/4 displays chromosome 17 on normal levels compared to HCT116. 
Besides these changes, no other changes were observed of chromosomes that are 
expected to be disomic. The aCGH profile of the cell line HCT116 5/4 shows that most 
parts of chromosome 5 are amplified. However, some regions are present at lower levels 
displaying partial deletions. Also paints and M-FISH analysis showed that three of the 
four copies of chromosome 5 are smaller if compared to the fourth one, with one of the 
chromosome parts being translocated to chromosome 16. Since this cell line was used 
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for further detailed expression analysis, a 2x400 K high density aCGH analysis was 
conducted to exactly map the amplified chromosome regions (Fig. 8). 
 
 
 
Fig. 7: aCGH analysis of 
HCT116 cell lines. DNA 
levels are depicted in log2 
scale and aligned according 
to their genome position. 
Chromosome 5 is marked in 
green and chromosome 3 in 
red. The cell line HCT116 
shows amplification of parts 
of chromosome 8, 10 and 17 
as well as deletion of the Y 
chromosome. These changes 
are also present in the 
aneuploid cell lines. Besides 
amplification of the extra 
chromosome, mostly 
generated cell lines do not 
differ from their origin cell 
line HCT116 comparing the 
aCGH profiles. Aneuploid 
cell lines show clear 
amplification of the extra 
chromosome. The cell line 
HCT116 5/4 however, 
contains some parts of 
chromosome amplified 
whereas other parts seem to 
be present as in cell lines 
disomic for chromosome 5.  
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4.2.1.3 High resolution aCGH analysis of HCT116 5/4 cell line  
Chromosome regions of chromosome 5 that are not tetrasomic were mapped by 
performing a 2x400K high density aCGH analysis (Fig. 8). For this analysis the HCT116 
genomic DNA was used as a direct reference sample in the experimental setup. High 
density aCGH data allowed a clear identification of disomic regions of chromosome 5 
(blow out, Fig. 9). Gene regions that were not tetrasomic were excluded from the 
analysis. Moreover, corresponding mRNA and protein information was deleted from the 
dataset. 
 
Fig. 8: 2x400K high density aCGH for the cell line HCT116 5/4. DNA levels are depicted in log2 scale. 
HCT116 5/4 genomic DNA was directly compared to genomic DNA of HCT116. High density aCGH analysis was 
performed to exactly map the amplified and disomic chromosome regions of chromosome 5 as this cell line was 
used for detailed genome wide expression analysis. Chromosome 17 is amplified in HCT116 but not in HCT116 
5/4 as shown by previous aCGH analyses, therefore it appears below zero. The amplification and the deletions of 
chromosome 5 are clearly visible 
 
4.2.2 RPE-1 cell lines - generation and verification 
The second cell line which was used to generate aneuploid cells is RPE-1. This cell line 
was employed to show that results from HCT116 derived cell lines were not cell line 
specific. The cell line RPE-1, is derived from female primary retinal pigment epithelium 
and was immortalized by stably expressing hTERT (ATCC). Similar to HCT116, RPE-1 is 
a near diploid cell line which propagates its genetic material stably (Jiang, Jimenez et al. 
1999). The RPE-1 cell line is not derived from tumor tissues (ATCC). Therefore, cellular 
physiology of this cell line is expected to be more similar to the natural cellular status and 
is easier to cultivate than primary human cells from patient tissues which become 
senescent after short time. The RPE-1 as well as the RPE-1 H2B-GFP cell lines were 
kind gifts of Stephen Taylor (University of Manchester, UK). Chromosome 5 was added 
to the RPE-1 cell line and chromosome 21 was added to the RPE-1 H2B-GFP cell line by 
microcell fusion. Afterwards, aCGH analysis was conducted to confirm successful 
chromosome transfer (Fig. 9).   
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Fig. 9: aCGH analysis of 
RPE-1 cell lines. DNA 
levels are depicted in log2 
scale. The RPE-1 cell line 
shows partial amplification 
of chromosome 10, which is 
also found in all aneuploid 
RPE-1 cell lines. Analysis of 
RPE-1 with extra chromo-
some 5 showed that also 
chromosome 12 was ampli-
fied. The cell line with extra 
chromosome 21 only in-
corporated the long arm of 
the chromosome. Chromo-
some 5, 12 and 21 are 
depicted in green, purple and 
orange, respectively.  
 
 
 
 
 
As seen in the aCGH plots, RPE-1 cell line also displays a partial amplification of 
chromosome 10, however no other changes were identified. This is also seen in 
aneuploid cell lines derived from the RPE-1 or RPE-1 H2B-GFP cell lines. Analysis of the 
aCGH profiles of cell lines with transferred chromosome revealed that chromosome 5 
was successfully added to the cell line RPE-1. Unexpectedly, chromosome 12 was also 
amplified in this cell line (hereafter referred to as RPE-1 5/3 12/3. For the cell line with 
transferred chromosome 21 the aCGH analysis revealed that only the long arm of 
chromosome 21 was successfully added to the cell line. However, this should not affect 
the study of protein levels in aneuploid cells when included accurately into the analysis. 
Therefore, the created cell lines RPE1 5/3 12/3 and RPE-1 H2B-GFP 21/3 were used for 
proteome studies.   
 
4.3 Aneuploid cell lines display a growth delay  
As aneuploid cells such as yeast, mouse and human aneuploid cells were shown to grow 
slower compared to their euploid counterpart (Segal and McCoy 1974; Torres, Sokolsky 
et al. 2007; Williams, Prabhu et al. 2008) we monitored growth characteristics of our 
aneuploid cell lines. Growth curves were generated, counting cells during 1 to 5 days 
after seeding (Fig 10). Growth curves clearly show that aneuploid human cells derived 
from HCT116 grow slower compared to their disomic counterparts HCT116 or HCT116 
H2B-GFP. The tetrasomic cell line with one added copy of chromosome 5 grows 
comparably faster to the cell line with two additional copies of the chromosome, 
indicating that the growth delay may be dosage dependent (Fig. 10, right panel). This is 
in line with the growth delay observed for other aneuploid cells (Segal and McCoy 1974; 
Torres, Sokolsky et al. 2007; Williams, Prabhu et al. 2008), which was also suggested to 
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be dosage dependent (Torres, Sokolsky et al. 2007). In conclusion, our aneuploid model 
cells show severe growth defects if compared to their disomic counterparts, which is in 
line with former studies. 
 
   
Fig. 10: Growth curves of HCT116 cell lines. 3x105 cells were seeded and counted every day. The cell line 
HCT116 grows faster than HCT116 5/4 (left panel) and HCT116 3/3 (middle panel). Also HCT116 H2B-GFP 5/3 
and 5/4 grow slower compared to HCT116 H2B-GFP (right panel). The cell line with one extra copy of 
chromosome 5 HCT116 H2B-GFP 5/3 grows faster than the cell line with two extra copies of chromosome 5 
HCT116 H2B-GFP 5/4. Experiments were performed in triplicates. The mean values are depicted; error bars show 
SD of mean. 
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4.4 The growth delay is due to a prolonged G1 and S phase   
4.4.1 Aneuploid cells grow slower due to increased time in interphase  
Growth defects of aneuploid yeast were shown to be due to a delay in G1 phase (Torres, 
Sokolsky et al. 2007). The cause for the growth delay of mammalian aneuploid cells 
however, remained unknown. A growth delay may be due to several reasons such as 
increased cell death level, prolonged cell cycle phase, complete arrest in a cell cycle 
phase or extensive cellular senescence. To address what is the origin of the reduced 
growth rate observed in cells with extra chromosome, cell death, cell senescence and 
live cell imaging experiments determining time in interphase and mitosis were performed 
(Fig. 11).  
 
 
Cell death levels were measured by propidium iodide (PI) exclusion experiment using 
FACS analysis. Data shows that the growth delay is not due to an increase in cell death 
rate of aneuploid cells. Even though HCT116 3/3 displays an increased cell death level, 
HCT116 5/4 has a cell death level below HCT116 (Fig. 11A). Notably, cell death rates 
are relatively low in all analyzed cell lines, and can therefore not be the reason for the 
A 
 
B 
 
 
Fig. 11: Aneuploid cell lines grow 
slower due to prolonged interphase. 
(A) Amount of dead cells was analyzed 
by propidium iodide (PI) exclusion 
experiment. HCT116 3/3 shows an 
increased level of dead cells whereas 
cell death level in HCT116 5/4 is lower 
than in HCT116. (B) HCT116 5/4 and 
HCT116 show similar levels of 
senescent cells, which were detected by 
β-galactosidase staining. (C) Live cell 
imaging following H2B-GFP positive 
nuclei by tracking the time from the 
onset of anaphase to the onset of the 
subsequent anaphase of the daughter 
cell revealed that HCT116 H2B-GFP 
5/4 shows a significantly prolonged 
interphase compared to HCT116 H2B-
GFP. (D) Time in mitosis, which was 
measured from the nuclear envelope 
breakdown (NEB) to the onset of 
anaphase was not perturbed in HCT116 
H2B-GFP 5/4 compared to HCT116 
H2B-GFP. All experiments were 
performed in triplicates, the mean 
values are plotted and the SEM is 
indicated by the error bars.  
C 
 
D 
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slow growth of aneuploid cells. Moreover, there was no increased tendency of HCT116 
5/4 to become senescent than HCT116 as confirmed by β-glactosidase assay (Fig. 11B). 
This assay makes use of the compound b-D-galactopyranoside (X-Gal) staining β-
galactosidase which is highly expressed in senescent cells (Dimri, Lee et al. 1995). As a 
control cells were treated for 7 days with 0.2 µM doxorubicin to induce senescence. 
Treated cells were clearly β-galactosidase positive, however, due to massive increase of 
cell size and unclear cell boundaries, data was not included in the graph. Live cell 
imaging analysis of nuclear H2B-GFP for 36 h, with automated image capture every 10 
min revealed that HCT116 H2B-GFP 5/4 (mean = 32,32 h) spend longer time in 
interphase than HCT116 H2B-GFP (mean = 21,32 h) (Fig. 11C). This could be observed 
for HCT116 3/3 and HCT116 5/4 in comparison to HCT116 as well (data not shown). As 
these cell lines lack the nuclear marker H2B-GFP cells were imaged every 10 min in 
bright field for 72 h (data not shown). In contrast, time in mitosis was not prolonged in 
HCT116 H2B-GFP 5/4 (mean = 26.85 min) in comparison to HCT116 H2B-GFP (mean = 
27.05 min) (Fig. 11D), as again analyzed by imaging H2B-GFP signal this time for 48 h 
every 4 min. As time in mitosis was similar in HCT116 H2B-GFP and HCT116 H2B-GFP 
5/4, mitosis can be excluded as the cause for the growth delay. To summarize, growth 
delay was neither due to cell death nor senescence in HCT116 H2B-GFP 5/4 but 
prolonged interphase. Further analysis was applied to pinpoint the specific cell cycle 
phase which leads to the growth defect in cell lines with an extra chromosome.  
 
4.4.2 Aneuploid cells display an increased G1 population 
To specify cell cycle phases in the aneuploid HCT116 cell lines, first, cell cycle profiles of 
unsynchronized, cycling cells were generated by FACS analysis using propidium iodide 
staining.  As seen in Fig. 12A, HCT116 5/4 showed an increased 2C peak whereas the 
4C peak is decreased, meaning that more cells are in G1 phase compared to G2 and/or 
M phase.  
Then the relative percentages of G1, S and G2/M phases from the cell lines HCT116, 
HCT116 5/4, HCT116 H2B-GFP, HCT116 H2B-GFP 5/3 and HCT116 H2B-GFP 5/4 were 
depicted (Fig. 12B). In line with the previous data, more cells of cell lines with extra 
chromosome aneuploids are present in G1 phase. This difference is significant between 
HCT116 and HCT116 5/4. At the same time fewer cells are present in G2 and/or M 
phase. Differences between HCT116 and HCT116 5/4 as well as between HCT116 H2B-
GFP and HCT116 H2B-GFP 5/3 or HCT116 H2B-GFP 5/4 are significant. The effect 
seems to increase with the extra chromosome number since HCT116 H2B-GFP 5/4 
displays more cells in G1 than HCT116 H2B-GFP 5/3. However, this effect was not 
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significant. In theory, the increase in G1 phase in aneuploid cells could be due to three 
reasons, first senescence, which displays the same DNA content as G1 phase, second 
slower progression through G1 phase or third faster progression through G2 and/or M 
phase. As shown above, time in mitosis was not altered between HCT116 H2B-GFP and 
HCT116 H2B-GFP 5/4. Moreover, senescence was not increased in HCT116 5/4 
compared to HCT116. Therefore, as aneuploid cells display an increased cell population 
in G1 phase, data suggests that aneuploid cell lines spend more time G1 phase. 
 
A 
 
 
Fig. 12: FACS cell cycle profiles of cell lines: cell lines with extra 
chromosome display an increased 2C population whereas 4C 
population is decreased. (A) Representative FACS profiles of 
HCT116 (blue) and HCT116 5/4 (green). FACS cell cycle profile of 
HCT116 5/4 displays an increased 2C population compared to 
HCT116, whereas 4C peak is decreased. (B) Relative percentages of 
cells in G1 and G2 and/or M phase of HCT116, HCT116 5/4 (left 
panel), HCT116 H2B-GFP, HCT116 H2B-GFP 5/3 and HCT116 
H2B-GFP 5/4 (right panel). HCT116 and HCT116 H2B-GFP are 
colored in blue, cell lines with extra chromosome in green. 
Significances are displayed as asterisk (unpaired T-test), the 
standard error is depicted in the error bars. All analyzed cell lines 
with extra chromosome showed increased 2C population, whereas 
the 4C population was decreased.  
B 
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4.4.3 Aneuploid cell lines display prolonged G1 and S phase 
To evaluate whether cells with extra chromosomes progress slower through G1 phase 
further experiments were conducted to pinpoint the duration of the different cell cycle 
phases. Therefore, cell cycle profiles by FACS analysis of HCT116 5/4 and HCT116 
were taken every 1.5 hours after thymidine release for 24 hours (Fig. 13).  
FACS cell cycle profiles obtained after thymidine release were evaluated by FlowJo 
software. Percentages of cells present in the specific cell cycle phases per time point 
were visualized in Fig. 13. Data shows that HCT116 5/4 spend longer time in S phase 
after thymidine release (Fig. 13B) compared to HCT116 (Fig13A). Moreover, G1 phase 
starts later than in HCT116 and is also prolonged compared to HCT116. In contrast, G2 
and/or M Phase are not affected. Notably, HCT116 5/4 were not equally well 
synchronized as HCT116, this may be due to their prolonged cell cycle which may need 
longer synchronization. In conclusion, growth defects of aneuploid cell lines are due to 
their delay in G1 and S phase and not due to cell death or senescence.  
 
 
 
 
Fig. 13: G1 and S phase are prolonged in HCT116 5/4 compared to HCT116. Cell lines were synchronized 
with thymidine and released from S phase. Cells were taken every 1.5 hours and were then fixed, PI stained and 
cell cycle profiles were analyzed by FACS. Percentages of cells in G1, S and G2/M were evaluated and depicted in 
the shown graphs. HCT116 5/4 (left panel) clearly shows a prolonged S phase after release if compared to 
HCT116 (right panel). Moreover cells progress slower through G1 phase, whereas G2/M is not affected. 
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4.5 Aneuploid cell lines adjust their protein levels    
mRNAs are expressed according to their gene copy number as described for trisomy 21 
cells, aneuploid MEFs and yeast cells (Mao, Zielke et al. 2003; Torres, Sokolsky et al. 
2007; Williams, Prabhu et al. 2008). However, detailed studies comparing DNA, mRNA 
and protein levels in aneuploid human cells are missing. To compare DNA, mRNA and 
protein levels of aneuploid cell lines with their disomic counterparts, aCGH analysis, 
mRNA array analysis as well as SILAC analysis were performed. Raw data was analyzed 
and processed by the MaxQuant software (Cox and Mann 2008). For normalization of 
aCGH data raw values were divided by their corresponding background signal. Then, 
aCGH and mRNA data of aneuploid cells were divided by aCGH and mRNA data from 
disomic cell lines, respectively, to allow comparison of abundance changes. As the 
median differed from zero, population was normalized by subtracting the median of the 
whole population from values. For analysis, DNA, mRNA and protein ratios were 
converted into log2 ratios.  
 
4.5.1 Correlation studies of replicates 
The aneuploid cell line HCT116 5/4 in respect to HCT116 was studied in most detail, 
since the dynamic range of measured changes from the extra chromosome is the highest 
among all model aneuploids. mRNA array analysis for HCT116 5/4 and HCT116 were 
conducted in biological triplicates which were converted into log2 ratios. Then, their 
medians were subtracted from each other. SILAC experiments were performed in 
biological triplicates including 6 measurements with one of them being a reverse labeling 
experiment. For the biological triplicates median ratios were calculated as well. Median 
ratios calculated from at least two biological replicates were used for analysis.  
To test for variability between technical and biological replicates as well as forward and 
reverse labeling, direct comparison of proteins was conducted. Technical and biological 
replicates show a high Pearson correlation factor between 0.79 and 0.84 (Fig. 14A,B). 
Whereas technical replicates and biological replicates generated by forward labeling are 
quite similar, comparison of forward and reverse labeling revealed that some proteins do 
not follow similar trends (Fig. 14C). However, enrichment analysis on the outliers did not 
show any pathway significantly enriched (data not shown) which shows that labeling 
does not affect specific pathways in these cell lines these and therefore should not 
influence the following analyses. 
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Fig. 14: Sample correlation of replicates from 
SILAC experiments. Proteins encoded on 
chromosome 5 are shown in yellow, all others in 
black. Pearson coefficients (r) are depicted. Axis 
are in log2 scale. (A) Technical replicates of 
HCT116 5/4 (E1_1 and E1_2). (B) Biological 
replicates of RPE-1 5/3 12/3 (Rep2 and Rep3) 
and (C) Label swap experiment of HCT116 5/4 
(E2 median = biological replicate 2 calculated by 
taking the median out of two technical replicates 
and E3 = reverse labeling experiment) are shown. 
Comparing forward and reverse labeling 
identifies proteins that do not follow similar 
trends. Analyzing these proteins by enrichment 
analysis did not show any significantly enriched 
pathway, indicating that altered proteins do not 
affect further pathway analysis.  
 
4.5.2 Matching HCT116 5/4 DNA, mRNA and protein information 
Aneuploid (HCT116 5/4) to diploid (HCT116) abundance changes of mRNA and DNA 
entries were directly matched to their corresponding protein entries using the annotated 
chromosomal position using the MaxQuant software (Cox and Mann 2008) (Fig. 15).  
Parts of chromosome 5 which were not at tetrasomic levels (threshold 0.65 (log2 scale)) 
were removed from the analysis leading to a “filtered” dataset (Fig. 15, magnified 
chromosome region). Corresponding mRNAs and proteins were removed from the 
analysis as well. One may speculate that some amplified chromosome parts, which 
contain gene information coding for proteins that are harmful to a cell are preferentially 
lost. However, enrichment analysis of gene information coded on the disomic 
chromosome parts showed no enrichment for a specific category in the disomic 
chromosome parts compared to the tetrasomic gene information. Comparison of 
aneuploid to diploid abundance changes of DNA, mRNA and protein data shows that 
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mRNA as well as protein levels highly vary around zero. Closer look on chromosome 5 
reveals that mRNA as well as protein levels of chromosome 5 are in average increased 
in HCT116 5/4. To study protein changes between HCT116 5/4 and HCT116 in detail 
density distribution graphs comparing protein abundance changes with their DNA and 
mRNA abundance changes were generated. 
 
 
 
 
 
 
 
 
Fig. 15: Comparison of 
DNA, mRNA and protein 
data obtained from the 
HCT116 5/4 cell line. 
DNA, mRNA and protein 
abundance changes of 
HCT116 5/4 in relation to 
HCT116 are depicted. 
Data is presented at log2 
scale and aligned by 
chromosome position. 
Each dot represents either 
an abundance change ratio 
of DNA, mRNA or 
protein. DNA and mRNA 
abundance change ratios 
were matched to a 
corresponding protein. 
Parts of chromosome 5 
that were not present at 
tetrasomic levels were 
removed from the analysis 
(magnified region). Data 
set with chromosome 
deletions is called 
“unfiltered” whereas the 
dataset with removed 
information is called 
“filtered”.  
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4.5.3 Comparison of mRNA and protein levels of chromosome 5  
To allow accurate comparison of aneuploid to diploid abundance changes between 
mRNA and proteins, density distribution graphs were generated using the R software. 
Comparison of mRNA and protein abundance changes of chromosome 5 by density 
distribution graphs clearly shows that whereas mRNAs are present according to gene 
copy number (median = 1.0993) proteins are down-shifted towards levels as expected in 
disomic cells (median = 0.6943). This shift was only observed for the tetrasomic 
chromosome and not for disomic chromosomes. Therefore, the down-shift of protein 
abundance changes is a specific phenomenon of proteins encoded on the extra 
chromosomes (Fig. 16). Indeed, 53 (27%) out of 197 proteins encoded on the tetrasomic 
chromosome 5 are show at abundance changes as expected for disomic chromosomes 
(calculated by taking the median +/- twice the standard deviation). The calculated median 
of abundance changes from these proteins is 0.26, while median of their mRNA is 1.16. 
In conclusion, abundance changes of mRNAs encoded on the extra chromosome are 
present as expected for their gene copy number whereas the abundance changes of 
proteins are present at lower levels. This indicates that aneuploid cell lines adjust levels 
of proteins encoded on the extra chromosome. 
 
 
 
 
Fig. 16: Comparison of mRNA and protein abundance changes by density distribution graphs. Density 
distribution plots of mRNA and protein abundance changes from all chromosomes excluding chromosome 5 (left 
panel) and from chromosome 5 only (right panel). Protein levels from chromosome 5 are down-shifted compared 
to mRNA levels. Medians are depicted. Differences of protein and mRNA distribution of chromosome 5 are 
statistically significant (Wilcoxon rank sum test). 
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4.5.4 Confirmation of data in other cell lines 
To confirm, that the down shift of protein abundance changes from proteins encoded on 
the extra chromosome is also observed in other aneuploid cell lines, SILAC experiments 
were performed for the cell lines HCT116 H2B-GFP 5/4, HCT116 H2B-GFP 5/3 and 
HCT116 3/3 (Fig. 17A).  
As for HCT116 5/4 aneuploid to diploid ratios were generated and log2 ratios were 
calculated. Then, abundance change ratios of proteins were matched and compared to 
their DNA abundance change ratios (Fig. 17). Furthermore, to show that the effects are 
not cell line specific, aneuploid RPE-1 cell lines were analyzed (RPE-1 5/3 12/3 and 
RPE-1 21/3) (Fig. 17B) and also their DNA abundance change ratios were matched to 
their protein abundance change ratios.  
As described above, density distribution graphs were generated using abundance 
change ratios of genome and proteome information of HCT116 3/3, HCT116 H2B-GFP 
5/3 and HCT116 H2B-GFP 5/4 cell lines in relation to HCT116 (Fig. 18A). Furthermore, 
to show that mRNA levels are present at gene copy number, mRNA array analysis was 
conducted for RPE-1 cell lines and mRNA aneuploid to diploid abundance changes were 
calculated. To clearly show that downshift of abundance changes is not already present 
at mRNA level mRNA and protein abundance changes were directly compared in density 
distribution graphs (Fig. 18B). Analysis of protein abundance changes from the extra 
chromosome in HCT116 3/3 showed similar trends as observed for HCT116 5/4. 25% of 
proteins encoded on chromosome 3 show abundance changes as expected for disomic 
chromosomes. In conclusion, aneuploid cells adjust proteins from the extra chromosome 
to a level as expected for disomic chromosomes. Moreover, this adjustment was present 
in all tested aneuploid cell lines with extra chromosomes, confirming that the abundance 
adjustment of proteins encoded on the extra chromosome is a general phenomenon. 
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Fig. 17: Comparison of DNA and protein data from cell lines with extra chromosome. DNA and protein data 
of the cell lines are depicted in relation to HCT116 data as log2 scale. Data is aligned by chromosome number. 
(A) DNA and protein data of the cell lines derived from HCT116: HCT116 H2BGFP 5/4, HCT116 H2BGFP 5/3, 
HCT116 3/3 and from RPE-1. (B) DNA and protein data of the cell lines derived from RPE-1: RPE-1 5/3 12/3 
and RPE-1 H2B-GFP 21/3.  
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Fig. 18: Comparison of genome and transcriptome or genome and proteome of cell lines with extra 
chromosome. (A) Density distribution analysis of DNA and protein levels in HCT116 cell lines with extra 
chromosome. Comparison of DNA and protein levels from the extra chromosome (red, lower panel) or from all 
chromosomes except the extra chromosome. Data from cell lines HCT116 3/3, HCT116 H2B-GFP 5/3 and 
HCT116 H2B-GFP 5/4 are depicted. (B) Density distribution analysis of mRNA and protein levels in RPE-1 cell 
lines with extra chromosome. Compared are mRNA and protein levels from the extra chromosome (red, lower 
panel) or from all chromosomes except the extra chromosome. Data from cell lines RPE-1 5/3 12/3 and RPE-1 
H2B-GFP 21/3, are depicted. Note that chromosome 12 and  chromosome 5 are depicted individually. Abundance 
levels of proteins encoded on the extra chromosome are clearly shifted towards disomic levels. 
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4.6 Kinases and subunits of protein complexes are preferentially 
adjusted in aneuploid cells  
4.6.1 Analysis of subunits of protein complexes  
The theory that subunits of complexes are compensated to similar levels has been 
proposed already years ago (reviewed in (Veitia, Bottani et al. 2008)). Recently, it was 
suggested that in aneuploid yeast subunit proteins encoded on the extra chromosome 
are compensated (Torres, Sokolsky et al. 2007; Torres, Dephoure et al. 2010). 
Therefore, we tested if specific groups of proteins may be preferentially adjusted in our 
cell lines by analyzing if an annotated category is significantly different from the 
population. 
 
  A 
 
 
 
B 
 
 
 
 
 
 
Fig. 19: Abundance of subunits of macromolecular complexes coded on the extra chromosome are 
regulated. (A) Density plots comparing subunits of macromolecular complexes (CORUM, black line) to the other 
proteins. Right panel shows the comparison of proteins from all chromosomes excluding chromosome 5. The left 
panel shows proteins from chromosome 5. Abundances of proteins encoded on chromosome 5 that are subunits of 
macromolecular complexes are clearly down-shifted. This shift is not observed for protein subunits encoded on all 
disomic chromosomes. Differences between populations are significant (Wilcoxon rank sum test). (B) 
Comparison of proteins from the amplified chromosome that are annotated as subunits of macromolecular 
complexes (CORUM, black line) compared to proteins that are not annotated in CORUM (red line). The cell lines 
HCT116 H2B-GFP 5/4, HCT116 H2B-GFP 5/3 and HCT116 3/3 are shown. The median is represented by dashed 
line. Asterisks indicate the significance (Wilcoxon rank sum test). 
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Fig. 20: Protein complexes with at least one 
subunit encoded on the extra chromosome 5. 
Proteins (red), mRNAs (blue) and corresponding 
DNA abundance changes (black) of subunits of 
macromolecular protein complexes containing at 
least one subunit coded on the extra chromosome are 
depicted. 9 out of 14 complexes contain at least one 
subunit that is present at lower levels than the 
corresponding DNA and mRNA. Some protein 
complexes show equal whereas other show variable 
protein abundance changes, indicating differences in 
adjustment of protein abundance of subunits. The 
medians with their interquartile ranges are depicted.  
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Indeed, abundance changes of protein subunits of macromolecular complexes (KEGG 
annotation: CORUM) significantly differed from the rest of the population, showing a clear 
downshift towards diploid level. Therefore, also mammalian aneuploid cells adjust protein 
subunits of complexes, similarly as suggested for yeast (Fig. 19A). In concordance, 
similar down-regulation was found in the cell lines HCT116 H2B-GFP 5/4, HCT116 H2B-
GFP 5/3 and HCT116 3/3 (Fig. 19B). Due to the high dynamic range of the tetrasomic 
chromosome 5 (HCT116 5/4) and our in depth analysis which provides ≈ 6000 proteins 
for analysis, HCT116 5/4 cell line was used for detailed analysis of abundance changes 
of protein subunits. Protein complexes annotated in the CORUM database that contained 
at least 5 protein subunits with at least one subunit coded on chromosome 5 were 
studied in detail. DNA, mRNA and protein abundance changes of these subunits of 
protein complexes were compared in detail. This revealed that 9 out of 14 complexes 
show a lower protein abundance change of at least one subunit encoded on the extra 
chromosome compared to their DNA and mRNA abundance changes (Fig. 20). Even 
though not all complexes displayed similar protein abundance changes, abundance 
changes of subunits encoded on the extra chromosome was most often shifted towards 
the median of the other complex subunits. In conclusion, protein subunits are not 
expressed according to gene copy number but to a lower level in aneuploid cell lines. 
Protein subunits encoded on the extra chromosome are in most cases adjusted to a level 
more similar to other subunits of the same complex.  
 
4.6.2 Analysis of protein kinases 
Another protein-group that was significantly different from the population was the 
category “kinases”. Whereas mRNA abundances (mean = 0.9018) were more spread, 
protein abundances were tightly centered around diploid level (mean = 0.2612) (Fig. 21). 
Analysis of protein abundance changes of kinases encoded on the extra chromosome 
revealed that kinases with abundance changes similarly as their respective gene copy 
number contain kinases that display function in pathways that were shown to be up-
regulated in aneuploid cell lines (e.g. JNK2). Kinases with protein abundance as 
expected for disomic chromosome, however, were not involved in any deregulated 
pathways. Due to lower protein number in proteome studies of other aneuploid cell lines 
and a small number of kinases encoding on extra chromosomes, this trend was not 
significant in any other aneuploid cell line. In conclusion, aneuploid cells show adjusted 
protein levels of proteins encoded on the extra chromosome with a preference for 
subunits of macromolecular complexes and most likely kinases.  
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Fig. 21: Proteins kinases of the extra 
chromosome are regulated. Depicted are all 
kinases encoded on chromosome 5 in HCT116 5/4. 
DNA abundance is shown in black, mRNA 
abundance in blue and protein abundance in red. 
Data is shown in log2 scale. Whereas mRNA levels 
are more spread, protein abundance is clearly 
down-shifted compared to DNA level. 
 
 
 
4.7 Aneuploid cells show a distinct cellular response 
Previous analysis on mRNAs in aneuploid yeast revealed changes in expression of some 
mRNA groups under growth limiting conditions, such as up-regulation of ribosome 
biogenesis and down-regulation of carbohydrate metabolism (Torres, Sokolsky et al. 
2007). Furthermore, aneuploid cells display common characteristics which are not 
present in diploids, such as slow growth, sensitivity to protein stress, increased glutamine 
consumption as well as ammonium production (Torres, Sokolsky et al. 2007; Williams, 
Prabhu et al. 2008; Torres, Williams et al. 2010). These studies indicate that aneuploids 
show similarities in cellular physiology that differ from diploids. Moreover, it was shown 
that aneuploid plant, yeast and mouse cells show a similar cellular aneuploidy specific 
responses (Sheltzer, Torres et al. 2012). 
To examine whether an extra chromosome causes a specific cellular response in the 
generated cell lines, pathway analysis was conducted. Therefore, SILAC data of various 
generated cell lines were analysed using the Perseus software (Cox and Mann 2012). 
The application “2-D annotation enrichment analysis” was used to study pathway 
regulations in aneuploid cells by testing if a category was significantly different from the 
rest of the population. This was done by applying a non-parametric two-sided Wilcoxon-
Mann-Whitney test. A 2% Benjamini-Hochberg false discovery rate was used to control 
for multiple hypothesis testing. Then, by combining significant abundance changes a 
relative regulation value between -1 and 1 of the significant categories is calculated. 
Comparing the data analysis revealed that the up- and down-regulated pathways of two 
cell lines highly correlate. This means that all tested cell lines with extra chromosome 
show a distinct cellular response. A high correlation of up- and down-regulated pathways 
was also found between HCT116 and RPE-1 derived cell lines with extra chromosome 
(Fig. 22A right panel). This suggests that the observed cellular response to aneuploidy is 
a general phenomenon and not cell line specific. Additionally, identified pathways were 
not up- and down-regulated due to increased gene copy number of genes encoded on 
the added chromosomes. Excluding proteins encoded on the tetrasomic chromosome 
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from the pathway analysis did not change the observed up- and down-regulated 
pathways (Fig. 22B). Pathways that are deregulated in cell lines with extra chromosome 
are regulated on transcriptional, and not only posttranslational level (Fig. 22C,D) as 
transcriptome and proteome data correlate well, as shown for HCT116 5/4 (Fig. 22C). 
Moreover, comparing only transcriptome data of cell lines with extra chromosome derived 
from two different parental cell lines also shows a high similarity of pathway deregulation. 
Pathways that are up-regulated in cell lines with extra chromosome are: membrane 
metabolism, energy metabolism, endoplasmatic reticulum (ER) and lysosome. Pathways 
that are down-regulated in cell lines with extra chromosome are pathways involved in 
DNA- and RNA-metabolism.  
To analyze the most up- or down-regulated pathways more detailed, box plots were 
generated with the extracted categories from all analyzed cell lines (Fig. 23). Abundance 
changes of proteins from the annotated category were plotted next to their information on 
DNA abundance from the corresponding genome position. Analysis was conducted for 
the up-regulated pathways Fig 23A) “lysosome” and “carbohydrate catabolic process” 
and for the down-regulated pathways (Fig. 23B) “spliceosome” and “DNA replication”. 
Box plots confirmed the clear up- and down-regulation of the selected pathways. During 
this study, it was published that aneuploid MEF cells also display a distinct pattern of 
deregulated pathways which was similar in all tested aneuploid MEF cells (Sheltzer, 
Torres et al. 2012). In line with our data they observed similar pathways down regulated 
such as DNA replication and chromosome segregation, pathways which were up-
regulated are extracellular region and response to stress. This indicates that aneuploid 
cells show deregulated pathway patterns that are similar between all tested aneuploids of 
the same species. This was shown for yeast, mouse and in this study for human 
aneuploid cells.  
To summarize, aneuploid cell lines show a distinct pattern of pathway de-regulation 
which was similar even between aneuploids derived from different cell lines. Pathway 
deregulation of mRNAs correlated with pathway deregulation of proteins, suggesting that 
pathway deregulation can already be studied on mRNA level. The category “lysosome” 
was one of the most up-regulated categories, which was found in all tested aneuploids. 
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Fig. 22: Aneuploid cells display a distinct cellular response. Two-dimensional (2-D) annotation enrichment 
analysis. Altered pathways between groups are plotted (Benjamini-Hochberg FDR threshold 0.02). (A) 
Deregulated pathways correlate between aneuploid HCT116 cell lines (left panel) and between aneuploid HCT116 
and RPE-1 cell lines (right panel). Pathway deregulation does not depend on specific chromosome but rather 
represents a general response to the extra chromosome. (B) Cellular response does not depend on the increase in 
gene copy number of genes coded on the added chromosome, as excluding the protein data from the added 
chromosome did not affect the cellular response. (C) Comparison of pathway regulation based on mRNA and 
protein data of HCT116 5/4 shows striking similarity. (D) This similar regulation pattern was also identified when 
only transcriptome datasets of two different aneuploid cell lines were compared.     
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Fig. 23: Examples for up- and down-regulated pathways in cells with extra chromosome.  Categories were 
extracted from the SILAC data and plotted in log2 scale. As a control DNA abundance changes of corresponding 
proteins were plotted nexto the protein abundance changes. Differences between DNA and protein abundances 
were all significant (unpaired T-test with Welch´s correction, P<0.05). (A) Two examples for up-regulated 
pathways, “lyosome” and “carbohydrate catabolic process”. (B) Two examples for down-regulated pathways, 
“spliceosome” and “DNA-replication”.    
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4.8 Aneuploid cells show increased autophagic and proteasomal 
activity 
4.8.1 Aneuploid cell lines show up-regulation of autophagic proteins 
As described above, cell lines with extra chromosome express 75% of the protein 
encoded on the added chromosome according to gene copy number. However, 25% of 
protein is adjusted to lower levels. Moreover, all cell lines with extra chromosome up-
regulate lysosomal proteins. The lysosome is a final step of a protein quality control 
system which degrades cellular material (Mizushima and Levine ; Yang and Klionsky 
2010). The best studied lysosomal protein degradation pathway is macroautophagy, 
hereafter referred to as autophagy.  
 
 
 
 
 
 
Fig. 24: Box plots of autophagic and proteasomal proteins in cells with extra chromosome. Box plots reveal 
that indeed autophagic proteins are up-regulated in most cell lines (upper panel). Only some cell lines with extra 
chromosome show up-regulated proteasomal proteins. This seems to be mainly true for cell lines with extra 
chromosome 5 (lower panel).  
 
 
Since cell lines with extra chromosome show increased lysosomal pathways and proteins 
from the added chromosome are adjusted towards levels as expected for disomes, we 
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hypothesized that aneuploid cell lines can degrade specific proteins encoded on the extra 
chromosome by autophagy.  
To first test whether proteins annotated in the category “autophagy” are up-regulated we 
generated boxplots with proteins and corresponding DNA levels comparing all aneuploid 
cell lines in relation to their respective control cell line with each other (Fig. 24, upper 
panel). This analysis indeed revealed that proteins of the category “autophagy” are up-
shifted. To test whether proteasomal proteins are up-regulated in aneuploid cells as well, 
we plotted proteins from the category “proteasome” (Fig. 24, lower panel). Only some cell 
lines show up-regulated proteasomal protein levels. However, average levels of 
autophagic as well as proteasomal proteins were not significantly different to their aCGH 
levels for most cell lines (unpaired T-test), which is why they were not depicted in the 2-D 
annotation graphs. Analysis of proteasomal proteins with increased protein abundances 
of the category “proteasome” revealed that PSME1 (PA28α) and PSME2 (PA28β) were 
highly increased in the cell lines HCT116 5/4 and HCT116 H2B-GFP 5/4. PA28 is a part 
of the immunoproteasome. It was shown that PA28 activates the immunoproteasome 
and plays a role in MHC class I antigen presentation (Sijts and Kloetzel 2011). However, 
an up-shift of PA28 was mainly observed in the cell lines with extra chromosome 5 and 
may be a chromosome specific reaction. 
To summarize, cell lines with extra chromosome show increased levels of proteins 
annotated in the category “autophagy”, only some cell lines showed increased protein 
levels of proteasomal proteins. However, up-regulation was in most cases insignificant. 
 
4.8.2 Proteasomal activity is increased in some aneuploid cell lines 
An increase in proteasomal degradation can either be achieved by up-regulating 
expression levels of proteasomal subunits or by increasing proteasomal activity itself. 
Therefore, proteasomal activity may be even increased without amplified proteasomal 
subunits. To test whether proteasomal activity is increased in aneuploids, cells were 
seeded in equal amounts at the day of the experiment and proteasome activity was 
measured by applying an assay that measures the chymotrypsin-like protease activity 
associated with the proteasome. This assay revealed that proteasomal activity was 
increased in the cell lines HCT116 3/3 and HCT116 5/4 when compared to disomic 
HCT116 (Fig. 25 left panel). However, the cell lines HCT116 H2B-GFP 5/3 and HCT116 
H2B-GFP 5/4 did not show an increase in proteasomal activity (Fig. 25, right panel), even 
though HCT116 H2B-GFP 5/4 showed increased proteasomal protein levels. To 
conclude, proteasome activity was increased in two out of four tested aneuploid cell lines. 
Therefore, proteasomal degradation may play a role to maintain protein homeostasis in 
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some aneuploid cell lines. However, one has to note, that proteasomal degradation can 
be modulated at several steps (for details see discussion).	  
 
  
Fig. 25: Proteasomal activity of cell lines with extra chromosome. Proteasome activity was measured by 
monitoring the chymotrypsin-like protease activity. The disomic cell line was normalized to the value 1. The cell 
lines HCT116 3/3 and HCT116 5/4 show increased proteasome activity (left panel), whereas H2B-GFP containing 
cell lines with extra chromosome do not show any increase in proteasome activity (right panel). Experiment was 
performed in three independent biological triplicates. The mean with SEM is shown. Significance is indicated by 
the asterisk (unpaired T-test), proteasomal activity of cell lines HCT116 H2B-GFP 5/3 and 5/4 was not 
significantly altered compared to HCT116 H2B-GFP.  
 
 
 
4.8.3 Autophagic activity is increased in aneuploid cell lines 
Pathway analysis revealed that levels of lysosomal proteins are increased in all analyzed 
aneuploid cell lines. Furthermore, boxplot analysis of the proteins from the category 
“autophagy” showed that also autophagic proteins are slightly increased. This suggests a 
role of autophagy in maintenance of protein homeostasis in aneuploid cell lines. To 
confirm this hypothesis, we first wanted to show that autophagy activity is indeed 
increased in aneuploid cell lines. To test this, initial immunoblotting for the autophagic 
marker LC3 was conducted in various cell lines with extra chromosome.  Indeed, LC3-II 
which is an LC3 isoform that is incorporated into the autophagosomal membrane 
(Klionsky, Abeliovich et al. 2008) is up-regulated in the tested cell lines HCT116 5/4, 
HCT116 3/3 and HCT116 H2B-GFP 5/3 and 5/4 (Fig. 26A). Moreover, p62 a marker for 
selective autophagy (Johansen and Lamark) was found to be up-regulated as well (Fig. 
27A). Further immunofluorescence analysis showed distinct patterns of incorporated LC3 
into the autophagosomes and confirmed that LC3 is up-regulated in HCT116 5/4, since 
the mean intensity of LC3 foci was found to be significantly increased (Fig. 26B). 
 
*** 
** 
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Fig. 26: Autophagy is increased in cells with extra 
chromosome. (A) The autophagic marker LC3 and the 
marker for selective autophagy p62 are increased in cells 
with extra chromosome, as shown by immunoblotting. 
(B) Immunofluorescence of LC3 (green, left panel) 
highlights autophagosome which have a significantly 
higher mean intensity (right panel)(unpaired T-test, 
**P<0.01) in HCT116 5/4 compared to HCT116.        
(C) Autophagic flux assay, cells were  transfected with a 
plasmid encoding for LC3 double tagged with mRFP and 
GFP. Red foci indicate autolysosomes, whereas yellow 
foci show autophagosomes that did not fuse with the 
lysosome. Images show that HCT116 3/3 and HCT116 
5/4 contain more red foci compared to HCT116 (upper 
panel). After treating cells with bafilomycin (lower 
panel), an autophagy inhibitor, only yellow foci were 
observed. This is due to the lack of fusion of 
autophagosomes with the lysosome after drug treatment.  
  
 
Increased levels of LC3 and p62 could also result from a block of autophagy. To test 
whether the accumulation of p62 and LC3 is due to an increased autophagic activity flux 
or due to a block in the autophagic pathway, an autophagic flux assay was performed 
(Kimura, Noda et al. 2007) (Fig. 26C). This assay enables visualization of the dynamics 
of autophagy by transfecting a construct to the cells that encodes for LC3 double tagged 
with GFP and mRFP. If LC3 is incorporated into autophagosomes, mRFP and GFP 
should colocalize and therefore be yellow stained. However, if the autophagosome fuses 
with the lysosome, the green fluorescence is quenched, and LC3 is then visible in red. 
Thus, red foci indicate autolysosomes, whereas yellow shows autophagosomes before 
cell fusion. Comparing the cell lines HCT116 3/3, HCT116 5/4 and HCT116 with each 
other shows that cell lines with extra chromosome display increased levels of cells with 
red foci. After treating cells with bafilomycinA1 (hereafter referred to as bafilomycin), an 
autophagy inhibitor, autophagic flux is perturbed as shown by high level of yellow but 
only few to none red vesicles. Up-regulation of LC3-II levels and increase autophagic flux 
leads to the conclusion that autophagic activity is increased in our tested aneuploid cell 
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lines. Up-regulation of p62 suggests a role of selective autophagy in regulating aneuploid 
protein homeostasis. 
4.9 Aneuploid cell lines show increased p62-dependent autophagy 
4.9.1 p62 levels are increased in aneuploid cells 
Since p62 levels were found to be up-regulated in aneuploid cell lines, p62 
immunofluorescence experiments were performed to visualize its localization. p62 
staining was visible as distinct foci within the cells (Fig. 27A), which confirms that p62 
aggregates, as already reported (Kuusisto, Salminen et al. 2001; Bjorkoy, Lamark et al. 
2005). Additionally, quantification of the p62 aggregates in the cell lines HCT116, 
HCT116 3/3 and HCT116 5/4 which was performed by the software cell profiler 
confirmed that p62 is significantly up-regulated in aneuploid cell lines (Fig. 27B). 
Moreover, aggregates were more numerous and bigger in size in aneuploid cell lines. As 
expected, inhibition of autophagy by bafilomycin increased p62 levels further, which was 
also the case in HCT116. In line with the immunoblot staining, p62 staining by 
immunofluorescence confirmed that p62 levels are increased in aneuploid cell lines. 
Moreover, p62 forms aggregates, which are more numerous and bigger in size in 
aneuploid cell lines.  
A 
 
 
B 
 
 
 
 
 
Fig. 27: p62 foci are increased in cell lines with extra 
chromsome. (A) Staining of p62 (red) shows the distinct p62 
foci in HCT116, HCT116 3/3 and HCT116 5/4 cell lines.  
(B) Quantification of p62 foci by cell profiler software. Mean 
intensity per cell was plotted. p62 was significantly increased 
in cell lines with extra chromosome (unpaired T-test 
***P<0.001). Treatment of the cells with Bafilomycin, an 
autophagy inhibiting agent, showed that p62 levels could be 
further increased after inhibition. 
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4.9.2 p62 aggregates colocalize with ubiquitin 
It was reported, that p62 binds to ubiquitinated proteins and targets them for autophagic 
degradation (Pankiv, Clausen et al. 2007; Long, Gallagher et al. 2008; Kirkin, McEwan et 
al. 2009). Therefore, an immunofluorescence experiment was performed staining for 
ubiquitin (FITC, shown in green) and p62 (cy5, shown in red) (Fig. 29).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Ubiquitin and p62 foci are increased and colocalize in cells with extra chromosome. p62 is shown in 
red and ubiquitin in green. The tested cell lines HCT116 5/4 (upper panel), HCT116 3/3 (middle panel) and RPE1 
5/3 12/3 (lower panel) are depicted. Cells were either untreated or treated with bafilomycin to further increase p62 
and ubiquitin foci. Line intensities of representative areas are depicted on the right, p62 is indicated in red and 
ubiquitin in green.  
 
Increased levels of ubiquitin foci were observed in the tested cell lines HCT116 5/4 (Fig. 
28A) and HCT116 3/3 (Fig. 28B). These foci colocalized with p62 foci. The same 
observation was made in the cell line RPE1 5/3 12/3 (Fig. 28C). By using the line 
intensity tool of the slidebook software, graphs were generated showing the intensity of 
the cy5 and FITC signal from selected representative areas. To summarize, as expected 
p62 and ubiquitin colocalized in all cell lines but aneuploid cell lines had a more 
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pronounced p62 and ubiquitin staining than disomic cell lines. However, if ubiquitinated 
proteins are proteins encoded on the extra chromosome remains elusive. 
 
4.10 Aneuploid cells do not show increased sensitivity to 
autophagy inhibition 
4.10.1 Sensitivity of aneuploid cells to autophagy inhibiting drugs 
The experiments described above show a strong up-regulation of autophagic activity in 
aneuploid cells. Furthermore, we observed that some proteins, such as subunits of 
macromolecular protein complex are adjusted towards a level as expected in disomic cell 
lines. An intriguing speculation would be that proteins that are detrimental to the cells if 
imbalanced are degraded by autophagy. Therefore, interfering with autophagy should in 
theory hamper aneuploid cellular growth compared to their disomic counterparts. 
Moreover, it was reported that aneuploid MEF cells were more sensitive to chloroquine 
than their diploid counterparts (Tang, Williams et al. 2011). In contrast, another study 
showed that aneuploid yeasts were not sensitive towards similar drugs but showed 
distinct sensitivity which was dependent on the extra chromosomes (Pavelka, Rancati et 
al. 2010). To test if aneuploid cell lines are more sensitive for autophagy inhibiting drugs 
than their disomic counterparts, cell lines were treated with the autophagy inhibitors 
bafilomycin and chloroquine (Fig. 29). Live cell imaging analysis was performed while 
drug treatment was applied. Sensitivities of cell lines towards drug treatments were 
investigated by monitoring the time of cell death. Data was evaluated by using excel 
software, generating survival curves.  
 
4.10.2 Knockdown of p62 is not detrimental to aneuploid cells  
To study whether aneuploid cell lines are more sensitive to the inhibition of selective 
autophagy, knockdown of p62 (Fig. 30) was conducted. A live cell imaging experiment 
was performed after p62 knock down. Time in interphase as well as cell death levels 
were monitored. However, neither cell death (data not shown) nor time in interphase (Fig. 
30A) was significantly altered in the HCT116 5/4 cell line with decreased levels of p62 
compared to the cell line treated with control siRNA. Please note that this may be due to 
the low knock down efficiency (Fig. 30B). However, if p62 amplified levels in aneuploid 
cells were crucial for their survival, even a knock down towards levels as expected for 
diploid cell lines should lead to an effect. Therefore, data indicates that increased p62 
levels are not required for aneuploid cell survival. 
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Fig. 29: Cell death after bafilomycin and chloroquine treatment. HCT116 cell lines (left panel) and HCT116 
H2B-GFP cell lines (right panel) after bafilomycin (upper panel) and chloroquine (lower panel) treatment. 
HCT116 are depicted in black, cell lines with extra chromosomes 5 in green and cell lines with extra chromosome 
3 in red. HCT116 3/3 is more sensitive to bafilomycin, HCT116 5/4 and HCT116 H2B-GFP are less sensitive. 
Aneuploid cell lines showed all decreased sensitivity to chloroquine.  
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Fig. 30: p62 knockdown is not detrimental to cells with extra chromosome. (A) Time in interphase was 
measured after knock down of p62. There was no significant increase (unpaired T-test)  in time of interphase after 
knockdown for the cell line HCT116 5/4 compared to the control siRNA. (B) Western blot of p62 levels. p62 
knockdown was only a partial knockdown. Western blot shows that p62 were reduced in HCT116 and HCT116 
5/4 p62 siRNA treated cells but not completely knocked down. 
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4.11 Proteins coded on chromosome 5 are not increased after the 
inhibition of autophagy  
If proteins encoded on the extra chromosome are degraded by autophagy one could 
speculate that inhibiting autophagy would lead to an accumulation of proteins encoded 
on the extra chromosome. Ideally, inhibition of autophagy should rescue the phenotype 
of adjusted protein levels. Therefore, to fully block autophagy 10 nM bafilomycin was 
added to the cells for 30 hours and protein levels were identified by mass spectrometry. 
For analysis, untreated as well as well as bafilomycin treated HCT116 5/4 and HCT116 
were used and compared with each other.  
 
 
 
 
 
Fig. 31: Changes of protein 
abundance after inhibition of 
autophagy. Density distribution 
graphs of bafilomycin treated 
HCT116 5/4(upper panel) and 
untreated HCT116 5/4 (lower 
panel) in relation to HCT116 
treated and untreated, 
respectively. Green line shows 
protein density distribution of 
proteins encoded on all 
chromosomes except 
chromosome 5, red line shows 
protein distribution of proteins 
on chromosome 5. Median of 
proteins encoded on 
chromosome 5 is at 0.8031 in 
treated and 0.7771 in untreated 
cells. Therefore, changes of 
protein abundance upon 
bafilomycin treatment do not 
increase after bafilomycin 
treatment. 
  
 
After bafilomycin treatment, abundances of proteins encoded on the extra chromosome 
do not increased significantly (Fig. 31 “treated” median = 0.8031 vs. “untreated” median = 
0.7771). Since the differences may be subtle, proteins encoded on the added 
chromosome were separated into the categories “CORUM” and “non-CORUM” to filter for 
proteins that are subunits of complexes which were shown to be significantly down-
shifted before (Fig. 32). The graphs “treated” and “untreated” show density distribution 
graphs of protein abundance changes between treated HCT116 5/4 and treated HCT116 
as well as untreated HCT116 5/4 and untreated HCT116, respectively. Subunits of 
protein complexes show a median of 0.577 in treated HCT116 5/4 compared to treated 
HCT116 and a median of 0.6023 in untreated HCT116 5/4 compared to untreated 
HCT116. This shows that subunits of complexes encoded on chromosome 5 are not up-
shifted after bafilomycin treatment. Therefore, inhibition of autophagy does not lead to an 
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accumulation of compensated protein indicating that autophagy may not be the cause for 
the down-regulation of subunits of complexes in cell lines with extra chromosome.  
       treated
 
    untreated
 
Fig. 33: Inhibition of autophagy does not lead to an upshift of subunit proteins encoded on chromosome 5. 
Density distribution graph of log2 ratios of proteins encoded on chromosome 5 from bafilomycin A1 treated 
HCT116 5/4 vs. treated HCT116 (left panel) as well as untreated HCT116 5/4 vs. untreated HCT116 (right panel) 
separated into the categories “CORUM” (thick line) and “not in CORUM” (thin line). Medians are depicted in the 
graph. Subunits of complexes encoded on the added chromosome 5 are not upshifted after bafilomycin treatment.  
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Cells with altered chromosome numbers are frequently found in cancerous tissues, 
misscarriaged embryos as well as in disabled born children such as trisomy 21 patients 
(Holland and Cleveland 2012; Nagaoka, Hassold et al. 2012). In the last decades studies 
on aneuploid tissues and embryos documented that changes in chromosome number 
lead to growth retardation and in most cases to embryonic lethality (Segal and McCoy 
1974; Hodgkin, Horvitz et al. 1979; Magnuson, Debrot et al. 1985; Toikkanen, Joensuu et 
al. 1993).  In contrast, as many cancerous tissues display high levels of cells with altered 
chromosome number, the idea was born that these cells could benefit from altered 
protein expression levels due to changes in chromosome number and outcompete cells 
with normal diploid chromosome content (Li, Yerganian et al. 1997; Storchova and 
Pellman 2004; Duesberg, Li et al. 2006). Although the phenotypes of cells and tissues 
with altered chromosome numbers were described for decades, underlying mechanisms 
that lead to the aneuploidy phenotype remain unknown. To address how aneuploidy 
affects cellular physiology initial studies were performed to test the effect of altered 
chromosome number on gene expression levels. Studies employing aneuploid budding 
yeast, mice and human cells elucidated that cells with extra chromosome scale their 
mRNA levels according to their gene copy number (Kahlem, Sultan et al. 2004; Upender, 
Habermann et al. 2004; Torres, Sokolsky et al. 2007; Williams, Prabhu et al. 2008)(Mao, 
Zielke, Zielke 2003). On protein level buffering mechanisms for subunit proteins of 
macromolecular complexes in aneuploid maize, yeast and flies were suggested (Birchler 
and Newton 1981; Devlin, Holm et al. 1982; Torres, Dephoure et al. 2010). Recent 
developments of Mass spectrometry technology and data analysis tools are emerging 
allowing more detailed and comprehensive analysis of whole proteomes. Therefore, in 
depth analysis of dosage dependent proteome levels in comparison to their DNA 
information of aneuploid cells may lead to new insightful information.  
To answer the question how an extra chromosome affects gene expression in human 
cells, human aneuploid cell lines were constructed and transcriptome as well as 
proteome were analyzed. This study revealed that, mRNA levels of genes coded on the 
extra chromosome scale according to gene copy number, whereas protein levels of some 
proteins encoded on the extra chromosome are adjusted to a level lower than gene copy 
number. This was especially the case for proteins being a subunit of a protein complex 
as well as kinases. Analysis of pathways deregulated in cells with extra chromosome 
revealed a distinct response to aneuploidy, which was found in all analyzed aneuploid 
cell lines. Interestingly, lysosomal proteins were significantly increased in aneuploid cells 
and further studies showed that autophagy, a lysosomal degradation pathway, is 
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activated in all analyzed aneuploid cells. Since also the autophagic receptor p62, which 
mediates selective degradation of protein was found to be increased in aneuploid cells 
one may speculate that p62 dependent autophagy is important to maintain adequate 
protein stoichiometries in aneuploid human cells.  
 
5.1 Mammalian aneuploid model systems  
Aneuploid studies have been performed in various sorts of mammalian cell systems. 
Here I will summarize advantages and disadvantages of different mammalian aneuploid 
cell systems and compare them to the system which was used in this study.  
One possibility to create aneuploid cells is by interfering with the SAC. Mice studies with 
defective SAC leading to mice with chromosomally instable cells were broadly conducted 
(Cahill, Lengauer et al. 1998; Dai, Wang et al. 2004; Baker, Jeganathan et al. 2006; 
Jeganathan, Malureanu et al. 2007; Sotillo, Hernando et al. 2007; Weaver and Cleveland 
2007; Weaver, Silk et al. 2007). However, as in this cell model aneuploid cells arise due 
to chromosomal instability, it is difficult to dissect whether observed phenotypes are 
caused by aneuploidy or chromosomal instability or may be even caused by the lack of 
another unknown function of the defective SAC components. To create stable aneuploid 
cells another study generated aneuploid mouse embryos by crossing mice each 
containing specific Robertsonian translocations (Williams, Prabhu et al. 2008) and 
isolated their MEF cells for experiments. Freshly isolated MEF cells display a 
homogeneous karyotype.  However, cultivation of MEF cells quickly leads to 
polyploidization and immortalization with resulting cell cultures containing various 
different aneuploid cell types (Todaro and Green 1963). Non-immortalized MEF cells are 
difficult to cultivate and handle and comparison between cell lines may be difficult, since 
immortalization occurs quickly. Therefore, aneuploid MEF cells are difficult to use for 
experiments that require long passaging. One of the earliest studies on mRNA 
expression levels in aneuploid cells made use of a trisomy 21 mouse model isolating 
various tissues and performing transcriptional analysis by cDNA array analysis and 
realtime PCR (Kahlem, Sultan et al. 2004). Tissue cells are suitable for quick endpoint 
analyses, however using tissue cells for cellular biology assays which require passaging 
is difficult as primary tissue cells grow poorly and become senescent after few passages. 
To overcome this problem, we and two other groups (Upender, Habermann et al. 2004; 
Nawata, Kashino et al. 2011) created aneuploid cell lines by adding an extra 
chromosome to stable human cell lines by microcell fusion technique (Fournier 1981; 
Haugen, Goel et al. 2008) resulting in cells that are aneuploid and easy to cultivate. 
Despite the advantages, one has to note that parental cell lines display already changes 
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when compared to normal tissue cells. HCT116 is a male, near diploid colorectal cancer 
cell line with a high level of microsatellite instability but low chromosomal instability 
(Lengauer, Kinzler et al. 1997). However, the HCT116 cell line already displays some 
inherent genome alterations (45,X,Y,dup(10)(q24q26),der(16)t(8;16)q13;p13),der(18) 
t(17;18)(q21;p11.3) (Masramon, Ribas et al. 2000). Thus, we used a second cell line, the 
RPE-1 cell line that contains fewer changes compared to HCT116 with only a small part 
of chromosome 10 partially amplified. Moreover, the RPE-1 cell line is a primary epithelial 
cell line immortalized by h-TERT and therefore closer to normal cells. Despite inherent 
alterations of HCT116 and RPE-1, these cell lines were used for these experiments as 
they are already well studied and frequently used as stable cell lines for genome 
instability research. Present alterations of parental cell lines may weaken specific 
aneuploid phenotypes of constructed cell lines with extra chromosome, however one 
would expect that adding a chromosome should lead to a clear enhancement if the 
phenotype depends on the DNA dosage.  Additionally, one has to take into account that 
adding an extra chromosome may be harmful or lethal to the cell as previously suggested 
(Thompson and Compton 2010). Therefore, cell lines used may contain alterations that 
allow propagation of aneuploid cells. To address whether cell lines with extra 
chromosome contain additional mutations compared to their parental cell line, detailed 
deep sequencing of cell lines with extra chromosome and their parental cell lines to 
compare mutations and their corresponding host genes is planned.  
To summarize, various mammalian aneuploid cell models were used in the past. Primary 
tissue cells proliferate poorly and become senescent after passaging. To allow detailed 
cell biological analysis which requires passaging we made use of a technique called 
microcell fusion by adding a chromosome to a stable cancerous or hTERT immortalized 
epithelial cell line. This allowed formation of cell lines which are relatively stable over time 
and easy to cultivate. One has to note that parental cell lines already differ by karyotype 
from natural tissue cells which may lessen the phenotypes observed in cell lines with 
extra chromosome. Moreover, it is possible that the cell lines with extra chromosome 
proliferate due to the acquisition of aneuploidy tolerating mutations, which will be tested 
in the future. RPE-1 and HCT116 cell lines containing an extra chromosome are 
hereafter referred to as aneuploid cell lines and parental cell lines are stated as diploids. 
 
  
 5 DISCUSSION  
61 
 
5.2 G1 and S phase delay in aneuploid cell lines 
Most whole embryo aneuploidies in humans lead to miscarriages and viable aneuploid 
humans show mental retardation and growth defects. Accordingly, cultured fibroblasts 
derived from Down syndrome patients grow slower in comparison to diploid fibroblasts 
(Segal and McCoy 1974) and hence, multiple other aneuploid organisms show severe 
growth defects such as yeast (Torres, Sokolsky et al. 2007; Pavelka, Rancati et al. 2010) 
worm (Hodgkin 2005), fly (Lindsley, Sandler et al. 1972) and mouse (Williams, Prabhu et 
al. 2008).  
Similarly to these findings, this study shows that aneuploid HCT116 cell lines grew 
significantly slower compared to their parental cell line. This growth delay was caused by 
an extended time in G1 and S phase, but not by elevated cell death levels or 
senescence. Similarly, previous findings in aneuploid yeast showed that the growth 
defect is due to a delay in G1 phase (Torres, Sokolsky et al. 2007) suggesting similar 
reasons of delayed growth in aneuploid yeast and human cells. However, initial studies in 
aneuploid MEF cells, analyzing FACS cell cycle profiles, did not show increased number 
of cells in G1 phase, even though they displayed growth delays (Williams, Prabhu et al. 
2008). As cell cycle profiles of aneuploid and diploid cells were similar and no increased 
level of cells in G1 phase was found the question remains why aneuploid MEF cells grow 
slower in comparison to diploid MEFs. To summarize, our created aneuploid cell lines 
grow slower compared to their parental cell line which is in line with previous findings. 
Aneuploid HCT116 grew slower due to prolonged G1 and S phase.  
As discussed later in this chapter cell lines with extra chromosome show a unique pattern 
of deregulated pathways that is similar in all tested cell lines. Pathways involved in DNA 
and RNA metabolism were down-regulated. Thus, the question is whether the slow 
growth of aneuploid cells is a cause or a consequence of the deregulated protein 
expression in aneuploid cell lines. Two scenarios are possible; aneuploid cell lines may 
grow slower due to deregulated expression of specific proteins (1) or deregulated 
expression of some proteins results from a delay which is caused by a specific burden 
inherent in all aneuploid cells (2) (e.g. DNA damage, protein stress). In the latter case up- 
and down-regulation of protein levels is a secondary effect due to the growth delay. 
Proteome data revealed that MCM2-7, which are components of the hexameric helicase 
are down-regulated in all aneuploid cell lines. Insufficient loading of the MCM complex 
components was hypothesized to trigger a checkpoint response leading to a delayed 
entry into S phase (Nguyen, Co et al. 2001; Ge and Blow 2009; Liu, Slater et al. 2009). 
Therefore, the hexameric helicase may play a role in aneuploids in regard to their cell 
cycle delay. However, why MCM complex components are down-regulated in aneuploid 
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cell lines and whether their down-regulation can be linked to the growth delay remains to 
be addressed in the future.  
Another possibility is that the cell cycle delay may be due to an increased need for 
energy of aneuploid cell lines. It was shown that aneuploid yeast and MEF cells consume 
more energy metabolites than diploid cells. The same study by Torres et al. showed that 
adding an untranscribed YAC to yeast cells does not lead to a growth defect as observed 
for aneuploid cells suggesting that the phenotype is not caused by the extra DNA, but 
rather by the expression of the extra genes.  (Torres, Sokolsky et al. 2007; Williams, 
Prabhu et al. 2008; Torres, Williams et al. 2010). In conclusion, authors hypothesized 
that the aneuploid cells require the extra energy for the expression and later degradation 
of the extra protein. Accordingly, lack of energy in cell lines with extra chromosome may 
delay multiple cellular functions in cell lines with extra chromosome and therefore delay 
cell proliferation. Subsequent studies showed that deletion of UBP6, coding for a de-
ubiquitinating enzyme, improves growth of aneuploid cells to a level similar to their 
euploid counterparts. Moreover, proteins from the extra chromosome were present at 
levels more similar to their euploid counterparts after deletion of UBP6. As lack of Ubp6 
leads to an increase in protein degradation, this indicates that increased protein turn-over 
can overcome the burden of aneuploid cells, most likely by increased degradation of 
excess protein from the extra chromosome. Therefore, data suggests that not increased 
energy need due to overexpression and degradation is the cause of the growth delay but 
rather the accumulating excess protein encoded on the extra chromosome. In 
conclusion, aneuploid cells seem to display an increased need for energy. If this is a 
cause of delayed growth remains unclear, however, recent studies rather pinpoint 
towards the extra protein as a burden to aneuploid cells. Why the expression of extra 
proteins is harmful to aneuploid cells is an interesting field of future research.  
Slow growth of aneuploids with one extra chromosome is in contrast to the theory that 
aneuploidization may trigger tumor formation. However, recent studies showed that 
aneuploid yeast cells display advantages towards certain conditions and moreover, can 
overcome their growth delay. Pavelka et al. created aneuploid yeast with complex 
aneuploid karyotypes which displayed growth advantages compared to the euploid 
control upon treatment with several chemotherapeutic and antifungal drugs such as 
rapamycine and thioloutin. Interestingly, authors showed a dependency between type of 
aneuploidy and drug resistance, indicating that aneuploidy can provides certain 
advantages towards specific conditions (Pavelka, Rancati et al. 2010). In addition 
aneuploid yeast cells exhibited higher level of chromosomal instability (Sheltzer, Blank et 
al. 2011), which was lower at levels close to haploidy and increased the more the 
aneuploidy reached the 2N state. (Zhu, Pavelka et al. 2012). Inherent instability of 
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aneuploid cells could therefore lead to a mutator phenotype, which may result in fast 
growing cells over time. Therefore, one may hypothesize that aneuploid cancer cells with 
highly variable karyotypes and probably frequent doubling events (Carter, Cibulskis et al. 
2012) may display an increased inherent chromosomal instability in comparison to 
normal diploid cells. Due to increased chromosomal instability, cells could gain or lose 
functions which may make aneuploid cells grow faster. As described above, another 
study revealed that even less complex aneuploid disomic yeast cells could overcome 
their growth delay after prolonged cultivation by gaining aneuploidy tolerating mutations 
e.g. UBP6 deletion (Torres, Dephoure et al. 2010). As discussed above, UBP6 deletion 
was suggested to increase proteasomal turnover and facilitate degradation of excess 
protein encoded on the extra chromosome (Torres, Dephoure et al. 2010). This indicates 
that aneuploid cells can overcome their growth delay if additional changes can 
compensate for their putative burden. Further research is required to dissect the role of 
aneuploidy towards chromosomal instability and tumorigenesis as well as the function of 
differentially expressed proteins. Notably, slow growth of freshly generated aneuploid 
cells does not exclude their evolutionary advantages. Therefore, increased chromosomal 
instability as well as gain of beneficial mutations may lead to advantages of aneuploid 
cells towards their diploid counterparts and may provide a model for tumorigenesis 
caused by aneuploidy.  
To summarize, aneuploid cells display a marked growth delay, which was also confirmed 
by this study. We show that growth delay of human aneuploids is due to prolonged G1 
and S phase. Slow growth of aneuploids is in contrast to the hypothesis that aneuploidy 
can facilitate tumorigenesis. However, other studies showed that aneuploidy can be 
beneficial under certain conditions e.g. if treated with certain drugs. Moreover, aneuploid 
cells were shown to display higher levels of chromosomal instability and growth delays, 
which were abolished upon certain aneuploidy tolerating mutations (e.g. UBP6 deletion). 
Increased chromosomal instability in combination with mutations that allow aneuploid 
cells to grow faster and to gain advantage towards certain stressful conditions could 
therefore provide an explanation for a role of aneuploidy in cancer formation. Further 
studies on how aneuploidy can affect evolutionary development of a cell population need 
to be determined.   
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5.3 Analysis of transcriptome and proteome in aneuploid cell lines 
In the past decades several studies were performed to elucidate dosage dependent gene 
expression levels in aneuploid cells. First studies in aneuploid plants showed that 
transcriptional expression levels of most genes do not scale according to gene copy 
number (Guo and Birchler 1994), similarly as in aneuploid fly cells (Zhang, Malone et al.). 
However, studies of aneuploid yeast and mouse cells showed that in yeast as well as in 
mouse cells mRNA are transcribed in a dosage dependent manner (Amano, Sago et al. 
2004; Upender, Habermann et al. 2004; Torres, Sokolsky et al. 2007; Williams, Prabhu et 
al. 2008). Studies on protein levels in aneuploid cells show different outcomes as well. 
Buffering mechanisms for subunit proteins of macromolecular complexes in aneuploid 
maize and flies were suggested already more than 30 years ago (Birchler and Newton 
1981; Devlin, Holm et al. 1982). Accordingly, a recent study on protein levels in aneuploid 
yeast showed that proteins scale mostly according to their gene copy number, with the 
exception of approximately 20% of proteins that are compensated, mainly being subunits 
of a macromolecular complex (Torres, Dephoure et al. 2010). In contrast, yeasts with 
complex karyotypes were shown to express protein encoded on extra chromosomes 
according to gene copy number with no significant compensation of a specific protein 
group (Pavelka, Rancati et al. 2010).  
Recent improvements in depth and analysis of mass spectrometry output allows more 
detailed and accurate analysis of whole proteomes. When this study was initiated, a 
detailed global analysis between genome, transcriptome and proteome of different 
human cell lines was a challenging and pioneering idea. By then whole organism 
proteome studies were only conducted in yeast comparing the proteome of haploid and 
diploid yeast (de Godoy, Olsen et al. 2008). Till today this study is the only 
comprehensive study in human cells comparing genome, transcriptome and proteome 
with each other. To first analyze how proteome in relation to transcriptome changes in 
human aneuploid cell lines, mRNA and protein levels were quantitatively analyzed and 
compared to their genome information. This revealed that mRNA levels in human 
aneuploid cell lines scale according to gene copy number (cell line with extra 
chromosome 5; median of 1.09 for mRNA (log2 ratio)) similarly to former mammalian cell 
studies (Mao, Zielke et al. 2003; Amano, Sago et al. 2004; Williams, Prabhu et al. 2008). 
As expected, the median aneuploid to diploid ratio of DNA, mRNA and protein of disomic 
chromosomes ranges around 0 (DNA: 0.005, mRNA: -0.03, proteins: -0.06). Interestingly, 
average aneuploid to diploid ratio of proteins encoded on the added chromosome did not 
scale according to gene copy number but were shifted to a value of 0.69. Further 
analysis revealed that 53 out of 197 proteins (27%) encoded on the extra chromosome 5 
or 25% encoded on extra chromosome 3 are not expressed according to gene copy 
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number. Enrichment analysis of proteins whose abundance change did not scale 
according to gene copy number revealed that proteins that are subunits of complexes are 
enriched in this population. Moreover, after analyzing whether other protein groups are 
preferentially downshifted, we found that kinases show a bimodal distribution, with 
several kinases present at lower levels, whereas other kinases were up-shifted. These 
were associated with pathways up-regulated in cell lines with extra chromosome (e.g. 
JNK2) (for pathway analysis see the chapter “Pathways analysis of aneuploid cell lines”). 
Analysis of complexes with at least one subunit coded on the extra chromosome 5 
revealed that some subunits coded on the extra chromosome seem to be regulated to a 
level closer to diploid level (8 out of 14, 57%). This result is in line with the hypothesis 
that dosages of subunits of the same macromolecular complexes are tightly regulated 
(Veitia, Bottani et al. 2008; Birchler 2010). The dosage balance hypothesis states that 
stoichiometry imbalances of subunits of macromolecular complexes can lead to dosage-
dependent detrimental phenotypes (Veitia, Bottani et al. 2008). As overexpression of an 
dosage-sensitive gene will lead to dosage changes of the whole complex (Birchler, 
Bhadra et al. 2001; Veitia 2002; Veitia 2003), proteins from the same complex are 
expressed at similar levels (Jansen, Greenbaum et al. 2002; Papp, Pal et al. 2003; 
Ettwiller and Veitia 2007). Accordingly, compensation of macromolecular subunits in 
aneuploid yeast was described before (Torres, Sokolsky et al. 2007; Torres, Dephoure et 
al. 2010) and this study shows that compensation of subunits encoded on the extra 
chromosome seems to be conserved from yeast to human. In contrast, Pavelka et al. 
could only see an insignificant compensation of specific protein groups such as subunit 
proteins in aneuploid yeast (Pavelka, Rancati et al. 2010). This could be caused by 
technical differences between their proteome analysis (MudPIT versus SILAC) as well as 
using yeast with more complex aneuploidies, which could hide compensatory protein 
changes in the analysis. The dosage balance hypothesis has been recently expanded to 
proteins that are required to maintain normal function of cellular physiology (Veitia 2005), 
which is in concordance with the compensation of kinase proteins in our study. Thus, 
regulation of subunits of macromolecular complexes and kinases encoded on the extra 
chromosome is in line with the dosage balance hypothesis and with former studies 
performed in yeast and suggests that dosage compensation of certain proteins is 
conserved between yeast and humans. Transcription factors showed similar trends, but 
could not be evaluated because of the small number in our data set.  
The mechanism by which subunits and kinases are compensated remain speculative. 
Regulation of gene transcription can be excluded as transcripts scale according to gene 
copy number in human cells. Therefore, protein expression of subunit proteins and 
kinases is only achieved by modulating protein levels, which could be done at several 
levels (e.g. protein degradation, modulating translation rates). It was shown that 
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incorporation of proteins into a complex may increase their thermal stability (Buchler, 
Gerland et al. 2005) and disorder of proteins was shown to correlate with protein half-life 
(Tompa, Prilusky et al. 2008). Moreover, it was suggested that proteins that are 
incorporated into a complex most likely escape from proteasomal degradation (Asher, 
Reuven et al. 2006). Function of the subunit, the topology and the kinetics between 
interacting subunits may affect the dosage dependent phenotype (Veitia, Bottani et al. 
2008) when a subunit for example forms a bridge between other subunits, 
overexpression of this subunit may result in the formation of inactive sub-complexes 
(Veitia, Bottani et al. 2008), which may lead to more detrimental phenotypes if over-
expressed. Therefore, subunits may be differentially regulated depending on their 
function and kinetics. Whether regulation could be facilitated actively or is a result from its 
instability remains elusive. Instability of free subunits as well as differences in kinetics 
and subunit function could lead to various types of regulation of subunits from the same 
complex. This may explain different patterns of subunit expression in analyzed 
complexes with at least one subunit encoded on the extra chromosome as observed in 
this study. However, studies on subunits encoded on the extra chromosome and their 
specific function in a macromolecular complex would require higher protein numbers as 
detailed information is not available for all subunits.  
In conclusion, our study shows that transcripts scale according to gene copy number 
whereas some proteins are adjusted towards lower levels, more similar to the abundance 
as expected for disomes. This is the case for most subunits of complexes as well as 
some protein kinases coded on the extra chromosome. Therefore, this study confirms 
that compensation of subunit proteins in aneuploid cells is conserved between yeast 
(Torres, Dephoure et al. 2010) and humans and supports the long standing hypothesis 
that subunits of complexes are compensated as overexpression leads to detrimental 
phenotypes (Veitia, Bottani et al. 2008). Compensation mechanisms remain elusive, 
however it was shown that proteins with high disorder that are not incorporated into 
complexes have a lower half-life than their incorporated counterparts and most likely 
escape proteasomal degradation (Asher, Reuven et al. 2006; Tompa, Prilusky et al. 
2008).  
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5.4 Pathway analysis in aneuploid cell lines  
As described above, aneuploid cells display severe growth defects, indicating that the 
addition of the extra chromosome is a burden to these cells. As we show here, aneuploid 
cell lines express proteins encoded on the extra chromosome. Many of them according to 
their gene copy number. This differential protein expression could lead to up or down-
regulation of other proteins or pathways. These pathways could either be altered similarly 
in various aneuploid cell lines or specifically depending on the type of extra chromosome. 
In other words, the pathway may be altered as a reaction to the set of amplified proteins 
or being a reaction to a common burden that the aneuploid cells face (e.g. protein stress, 
DNA damage) 
To test how cellular physiology is globally affected by an extra chromosome, pathway 
analysis was performed by creating 2-D annotation enrichment analysis (Cox and Mann 
2012). Remarkably, all tested HCT116 cell lines with extra chromosome show similar 
regulation patterns of up- and down-regulated pathways. Similar trends are also present 
in all RPE-1 cell lines with extra chromosomes. These effects are also clearly visible 
when proteins from up- and down-regulated pathways of different cell lines were plotted 
next to each other. Pathways involved in DNA and mRNA metabolism are down-
regulated (e.g.: replication, DNA repair, transcription and mRNA processing). Up-
regulated pathways involve lipid and membrane biogenesis, endoplasmic reticulum, 
Golgi vesicles, lysosome function as well as energy metabolism. Notably, observed 
pathway changes in aneuploid cell lines were not due to proteins encoded on the extra 
chromosome since removing this data from the analyzed dataset did not lead to any 
changes in pathway regulation. Moreover, effects were also not caused by labeling 
artifacts or a bias in protein detection as a reverse labeling experiment and mRNA 
pathway analysis showed similar results. The specific functions of most altered pathways 
in cell lines with extra chromosome remain speculative. Interestingly, proteins involved in 
energy metabolism were in average up-regulated, which is in line with former data, 
showing that aneuploid yeasts assimilate higher levels of glucose (Torres, Sokolsky et al. 
2007) and aneuploid MEFs increase their lactate up-take (Williams, Prabhu et al. 2008). 
Authors hypothesize that transcription and translation as well as degradation of the extra 
encoded proteins in aneuploid cells, require energy and that this leads to an increased 
need for energy metabolism.   
Most comprehensive studies on deregulated pathways in aneuploid cells were performed 
in yeast (Torres, Sokolsky et al. 2007; Pavelka, Rancati et al. 2010) with contradictory 
outcome. Pavelka et al. could not find a common pattern of pathway regulation in 
aneuploid yeast. In contrast, Torres et al. observed a transcriptional regulation pattern 
similar to the environmental stress response (ESR) in most aneuploid yeast cells. Here in 
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this study we did not identify a pattern similar to the yeast ESR in aneuploid cell lines. 
However, direct comparison of mRNA data would be needed to allow accurate 
comparison. Besides these yeast studies, the effect of aneuploidy on cellular physiology 
was tested in human transformed as well as cancerous cells with a transferred additional 
chromosome. Authors showed that multiple transcripts were deregulated across the 
whole genome however, no common aneuploidy specific deregulation pattern of 
pathways was reported (Upender, Habermann et al. 2004). Moreover, studies in 
Drosophila cells did not reveal any aneuploidy specific response (Zhang, Malone et al. ; 
Stenberg, Lundberg et al. 2009). However, just recently, gene expression of aneuploid 
yeast, plant, mice and human cells were directly compared to each other showing highly 
related expression patterns (Sheltzer, Torres et al. 2012). As Sheltzer et al. also showed 
that complex aneuploid yeasts display similar altered pathway patterns than yeast with 
single chromosome aneuploidies (Sheltzer, Torres et al. 2012) contradictory yeast data, 
described above are probably due to differences in data analyses. Differences between 
our study and the study by Upender et al. may also be caused by differing analyses as 
comparing their cDNA array data to our mRNA data revealed equally deregulation 
patterns (performed by Milena Dürrbaum, data not shown).  
As aneuploid cell lines grow slower we cannot exclude that the observed pathway pattern 
is due to their G1 and S phase delay. However, it is difficult to dissect pathways that are 
altered due to aneuploidy and pathways that are altered as a secondary effect due to 
their cell cycle delay. One possibility could be to grow cell lines in minimal medium or to 
synchronize cell lines to a level where aneuploid cell lines and control cell lines grow 
similarly and perform an mRNA or SILAC analysis. Similarly, aneuploid yeast cells which 
showed common pathway patterns similar to the ESR were grown under phosphate 
limiting conditions in a chemostat before mRNA array analysis. In contrast to cells under 
nutrient rich condition the only differences of aneuploid yeast in comparison to haploid 
yeast grown in the chemostat were down-regulation of carbohydrate metabolism and up-
regulation of ribosome biogenesis. Thus, authors hypothesize that pathways observed 
under normal growth conditions were due to the differences in doubling time. However, 
depletion of nutritions may lead to strong phenotypic responses that may alter or hide 
aneuploidy specific phenotypes as the aneuploidy phenotype is likely a combination of an 
increased energy demand and a changed protein turnover rate, and depletion of nutrition 
likely affects multiple similar functions. Therefore, these results may be even more 
difficult to interpret. In conclusion, the underlying reasons for common pathway 
deregulation patterns in aneuploid cells are difficult to interpret. Detailed answers may 
only be provided by further cell biological and biochemical research dissecting the 
molecular mechanisms underlying the changes of specific pathways. 
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Since aneuploid cell lines were shown to express protein encoded on the extra 
chromosome, we verified whether proteins involved in the protein stress response are 
increased. However, neither chaperones nor the category “heat shock response” was 
found to be significantly up-regulated. This finding supports the hypothesis that chronic 
protein overexpression does not induce the same response in cells as an acute protein 
stress (Gidalevitz, Ben-Zvi et al. 2006). Moreover, we could not find any up-regulation of 
proteins involved in unfolded protein response or ER-associated degradation (ERAD). 
To summarize, aneuploid cell lines show distinct common patterns of deregulated 
pathways. Further studies may elucidate why specific pathways in aneuploid cells are 
differentially regulated and how they affect cellular phenotype and what is their distinct 
function. Altered pathway regulation of aneuploid cells could open a new and exciting 
field of study to find therapeutics to treat aneuploid related pathologies. Therefore, 
treating aneuploid cancer cells with inhibitors targeting specific pathway that are required 
for aneuploid cell proliferation/survival may lead to aneuploid cell death. Finding 
treatments that allows aneuploid cells to grow faster may be beneficial for Down 
syndrome treatments. 
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5.5 Analysis of protein degradation mechanisms in aneuploid cell 
lines 
2-D Annotation enrichment analysis revealed that proteins from the category “lysosome” 
are more abundant in all aneuploid cell lines. The lysosome is known to degrade proteins 
that are either delivered via autophagosomes or directly directed to the lysosome. Up-
regulation of protein degradation pathways makes sense in the light of amplified protein 
expression with partial down-regulation of specific protein groups in cell lines with extra 
chromosome. Therefore, we analyzed proteins of the two major degradation 
mechanisms, autophagy and proteasome in our SILAC data in detail. This revealed that 
the abundances of autophagosomal proteins are slightly increased in all aneuploid cell 
lines. Moreover, the cell lines with two extra chromosomes 5 or the RPE-1 cell line with 
extra chromosome 5 and 12 also showed increased levels of proteasomal proteins, 
whereas other tested cell lines did not show any remarkable increase. The autophagic 
marker LC3-II was also up-regulated in all analyzed HCT116 cell lines with extra 
chromosome. It should be noted that an increase of proteasomal and autophagic protein 
levels does not generally mean that these degradation processes are more active or 
degrade the proteins that were shown to be downshifted towards diploid level. Further 
experiments revealed that also autophagic activity was increased in the cell lines 
HCT116 3/3, HCT116 5/4, HCT116 H2B-GFP 5/3 and HCT116 H2B-GFP 5/4, whereas 
proteasome activity was increased in HCT116 3/3 and HCT116 5/4. However, turnover 
by the proteasome may be modulated at multiple stages, such as increase of ubiquitin 
conjugation levels, increased transport to the proteasome or decrease of de-
ubiquitinating enzymes (Hoeller and Dikic 2009) which was not addressed in this study. 
Therefore, it may be possible that the proteasome activity is not altered itself but that 
turnover by the proteasome is still increased due to orchestrating ubiquitination and 
delivery to the proteasome. In conclusion, autophagic proteins as well as autophagic flux 
were increased in all tested aneuploid cell lines, whereas proteasomal proteins and 
proteasomal activity were only increased in some cell lines. However degradation by the 
proteasome may be modulated at multiple stages. 
Studies by Torres et al. indicate that aneuploid cells likely suffer from proteotoxic stress 
(Torres, Sokolsky et al. 2007). Moreover, the same group found that aneuploid yeast 
cells with a deletion for UBP6, a gene encoding for the de-ubiquitinating enzyme Ubp6 
(Borodovsky, Kessler et al. 2001; Leggett, Hanna et al. 2002; Guterman and Glickman 
2004) grow as fast as haploid yeast (Torres, Dephoure et al. 2010). Intriguingly, authors 
hypothesize that the extra proteins encoded on the added chromosome leads to the 
observed growth delay and after increasing proteasomal turnover the excess protein is 
effectively degraded, allowing these cells to overcome their growth delay. Moreover, it 
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was shown that aneuploid MEF cells were sensitive to the autophagy inhibitor 
chloroquinee (Tang, Williams et al. 2011), suggesting that autophagy is important for 
aneuploid MEF cells. Surprisingly, sensitivity to rapamycine as well as any tested 
proteasome inhibitor (lactacystin and MG132) was not significantly altered in aneuploid 
MEF cells, which would be expected if aneuploid cells require proteasomal or autophagic 
activity for survival or growth. In contrast to the data obtained with aneuploid MEFs or 
budding yeast, we could not find any aneuploidy specific response after drug treatment. 
Inhibition of USP14, the mammalian Ubp6 homologue, by 1-[1-(4-fluorophenyl)-2,5-
dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)-ethanone (IU1) (Lee, Lee et al. 2010)  did not 
improve cellular growth of aneuploid cell lines in a similar way as reported for aneuploid 
cells with the deletion of UBP6 in yeast (data not shown). Moreover, experiments 
performed during this study using autophagy inhibitors such as bafilomycin and 
chloroquinee did not reveal any unique response. Some cell lines with extra chromosome 
showed increased sensitivity compared to their parental cell lines, whereas others were 
less sensitive. This observation is rather in accordance with data obtained by Pavelka et 
al. describing that depending on the type of aneuploidy some yeast strains were less and 
some more sensitive to certain drugs than their euploid counterparts (Pavelka, Rancati et 
al. 2010). Therefore, the question remains if altered protein expression is more important 
for drug sensitivity of aneuploid cells than targeting e.g. their protein degradation 
pathways. Moreover, autophagy and the proteasome system work synergistically as it 
was shown that autophagy activity is stimulated after inhibition of the proteasome (Iwata, 
Riley et al. 2005; Pandey, Nie et al. 2007). Therefore, inhibition of one degradation 
mechanism may be compensated by the other and may not affect cellular survival, which 
influences the experimental result. Testing the sensitivity of aneuploid cell lines towards 
combined treatment of bafilomycin and MG132 could provide interesting insight into this 
question. What may be the reason for increased autophagic or proteasome activity is 
further discussed in the following chapter. 
To summarize, recent research illustrated that the extra protein encoded on the extra 
chromosome may be a burden for aneuploid cells. Yeast cells seem to circumvent this 
problem by degrading protein by proteasomal degradation whereas this study reveals 
that mainly autophagic degradation is up-regulated in aneuploid human cell lines. 
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5.6 p62 dependent autophagy is increased in aneuploid cell lines 
This study shows that p62, a selective autophagy receptor, is up-regulated in cell lines 
with extra chromosomes, which increased even more after treatment with the autophagy 
inhibitor bafilomycin. p62 sequesters misfolded or damaged ubiquitinated proteins and 
targets them to the autophagosome by interacting with LC3 (Bjorkoy, Lamark et al. 2005; 
Pankiv, Clausen et al. 2007). Immunofluorescence analysis revealed that in cell lines with 
extra chromosome, the p62 co-localization to ubiquitin is increased, suggesting a specific 
degradation mechanism in aneuploid cell lines.  
As described, p62 foci in aneuploid cell lines are increased compared to their parental 
cell lines. Since p62 sequesters ubiquitinated proteins and forms aggregates (Pankiv, 
Clausen et al. 2007; Kuusisto, Kauppinen et al. 2008; Wooten, Geetha et al. 2008), one 
can speculate about the nature of these foci. One appealing possibility could be that the 
extra proteins in aneuploid cell lines is sequestered by p62 and degraded via autophagy. 
Proteins from the extra chromosome might be harmful to the cell by perturbing cellular 
protein homeostasis. Moreover, proteins of cell lines with extra chromosome may be 
misfolded due to high load on the protein folding machinery as chaperones are not 
increased in cell lines with extra chromosome, but effectively more protein has to be 
folded. In line, protein degradation mechanisms were shown to play an important role in 
aggregate based neurodegenerative diseases (Alves-Rodrigues, Gregori et al. 1998; 
Webb, Ravikumar et al. 2003; Harris and Rubinsztein 2012). Recently, a more dominant 
role for autophagy in neurodegenerative diseases was proposed. Proteasomal 
degradation requires unfolding of the substrate to pass through the pore of the 
proteasome (Verhoef, Lindsten et al. 2002), therefore, aggregated proteins may be rather 
degraded by autophagy, which was shown to degrade e.g. bulk proteins, mitochondria 
and protein complexes (Johansen and Lamark). This could be an explanation why 
autophagy was shown to be up-regulated in all analyzed human cell aneuploids, whereas 
the proteasome is up-regulated only in some aneuploid cell lines with higher 
chromosome load (tetrasomic cell lines).   
Interestingly, p62 was shown to play a role in neurodegenerative diseases displaying 
accumulation of malformed or toxic proteins. Therefore, sequestered p62 is used as a 
marker for neuropathologies (Kuusisto, Salminen et al. 2001; Kuusisto, Kauppinen et al. 
2008) and overexpressed huntingtin was shown to be degraded via p62-dependent 
autophagy (Bjorkoy, Lamark et al. 2005). p62 colocalized with expressed huntingtin in 
human cell lines and interference with p62 function lead to a huntingtin dependent cell 
death (Bjorkoy, Lamark et al. 2005).  As also cell lines with extra chromosome may 
accumulate extra proteins, the role of p62 in these cell lines could be similar as for 
neurodegenerative diseases. In line, signs of mental retardation are present in 
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neurodegenerative diseases and patients with Down syndrome. Moreover, Down 
syndrome patients suffer from Alzheimer disease earlier and more often in life than 
healthy humans (Olson and Shaw 1969; Glenner and Wong 1984) and number of 
aneuploid cells is increased in Alzheimer diseased brain (Petrozzi, Lucetti et al. 2002). 
Research on neurodegenerative diseases pinpointed to the aggregates being the toxic 
species of neurodegenerative phenotypes. However, recently it was discussed that 
aggregates may be rather protective to the cell (Behrends, Langer et al. 2006; Douglas, 
Treusch et al. 2008; Douglas and Dillin 2010), as aggregation provides a tool to store 
harmful proteins in an inactive form. Effects of aggregates on cellular physiology e.g. as 
shown by Olzscha and colleagues may thus be tolerated by the cell as a protection from 
the worse. In this study authors could show that expression of artificial amyloids lead to 
the formation of aggregates, which attract other proteins. These proteins were reported to 
be relatively large in size and significantly enriched in predicted unstructured regions. 
Interestingly, aggregates were shown to contain in addition to the artificial amyloid 
multiple important cytosolic proteins such as proteins involved in chromatin organization, 
transcription, translation, maintenance of cell architecture and protein quality control 
(Olzscha, Schermann et al.). Conclusively, authors could show that indeed aggregates 
itself have an effect on the cell independent of their origin. If the sequestration of 
important cytosolic proteins by aggregates would be a general phenomenon, one could 
speculate that p62 associated aggregates arising in aneuploids can attract other proteins 
important for cellular function as well. This might be a possible explanation for the growth 
delay observed in aneuploid cells. Therefore, a general higher demand of protein 
degradation and an overload of the proteasome could lead to accumulation of either 
proteins from the extra chromosome or misfolded and damaged proteins that attract 
cytosolic proteins which are important for cellular function. Interestingly, a recent study 
showed that p62 increases in autophagy deficient mice, which leads to an increased in 
ROS levels, DNA damage and subsequently tumorigenesis (Mathew, Karp et al. 2009). A 
former study by the same group showed that autophagy suppresses chromosomal 
instability (Mathew, Kongara et al. 2007). Authors hypothesized that deficiency in 
autophagy leads to an accumulation of mitochondria and damaged proteins, which 
causes an increase in ROS. Interestingly, Sheltzer and colleagues could show that 
genome instability as well as DNA damage is increased in aneuploid yeast (Sheltzer, 
Blank et al. 2011) and also our cell lines with extra chromosomes show higher 
chromosomal instability than their parental cell lines (data not shown). Further studies 
should address whether aneuploid cell display increased ROS levels (1), show elevated 
levels of DNA damage (2), and accumulate mitochondria (3). If these experiments result 
in positive data, it may be interesting to test how activation of autophagy affects these 
factors.  
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Even though p62 as well as LC3-II are increased in aneuploid cell lines, it remains 
unclear whether proteins encoded on the extra chromosome are sequestered by p62 and 
actively degraded via p62 mediated autophagy. If p62 was important for cell lines with 
extra chromosome, its depletion should have detrimental effects. Knockdown of p62 in 
cell lines with extra chromosome did not lead to an increased delay in interphase nor did 
it lead to increased cell death levels. However, knockdown was only partial and another 
specific autophagy receptor NBR, which was shown to have a similar function as p62 
(Kirkin, Lamark et al. 2009) could compensate decreased p62 levels. Therefore, future 
experiments with double knockdown of p62 and NBR should be performed. To elucidate 
which proteins are associated with p62, p62 immunoprecipitation experiments followed 
by mass spectrometry analysis were performed (data not shown). Unfortunately, this 
technically challenging experiment did not lead to interpretable data since associated 
proteins were only present in very low concentrations. For mass spectrometric analysis, 
only the soluble fraction was used, however, aggregates may be rather present in the 
insoluble fraction. Therefore, it would be interesting to follow this path further in the 
future, either by optimizing the p62 immunoprecipitation conditions or by trying to use the 
insoluble fraction for analysis. Moreover, immunoprecipitation of ubiquitin in combination 
with subsequent SILAC analysis could identify, whether proteins from the tri- or 
tetrasomic chromosome are differentially ubiquitinated. Identifying proteins by ubiquitin 
pull-down however, does not answer the question how proteins are degraded. If the 
ubiquitination of proteins from the extra chromosome is significantly increased above the 
expected level, this may pinpoint to a function of ubiquitination in regard to protein 
degradation. Another possibility could be that other proteins are preferentially 
ubiquitinated in aneuploid cells (e.g. aggregation of damaged or old protein due to a 
higher demand to protein degradation machineries). However, analysis of ubiquitinated 
proteins may be difficult since as reported multiple pathways are altered in aneuploid 
cells. Therefore, ubiquitination status of proteins may be changed by the physiological 
response to aneuploidy but may not provide a clear answer which proteins are degraded 
via p62.  
To test whether the extra proteins encoded on the added chromosome accumulate after 
autophagy inhibition, bafilomycin was added to the cells for 30 hours followed by a 
quantification of protein levels by SILAC. Analysis of the levels of proteins encoded on 
the added chromosome did not reveal any significant difference as their levels were 
increased as in untreated conditions. This may have many reasons. First, proteins from 
the added chromosome may not be degraded by autophagy. As described above, the 
UPS could degrade protein encoded on the extra chromosome. Due to the overload of 
the proteasome by the extra proteins, autophagy would be needed to compensate the 
degradation of other misfolded or damaged proteins to maintain protein homeostasis. 
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Second, activation of autophagy could have secondary reasons. Aneuploid cell lines 
show up-regulated energy metabolism pathways and former studies showed that 
aneuploid cells have a higher demand of energy sources. Since autophagy is known to 
be activated due to starvation, increased p62 and LC3 levels may result out of nutrient 
deprivation. However, p62 was shown to accumulate with proteins specifically and 
increased p62 aggregation does not fit to the starvation hypothesis. Third, experimental 
setup is not suitable to test the hypothesis that proteins from the extra chromosome are 
degraded by autophagy. Bafilomycin was shown to inhibit autophagy. One study showed 
that bafilomycin inhibits the fusion of autophagosome and lysosome (Yamamoto, Tagawa 
et al. 1998), this was also confirmed in this study by autophagy flux assay, thus almost 
only yellow fluorescence was detected indicating that autophagosomes did not fuse with 
lysosomes. However, it is unclear whether prolonged bafilomycin treatment and therefore 
autophagy inhibition alters other pathways and metabolism besides autophagy.  
Therefore, it is possible that after inhibition alternative pathways such as proteasomal 
degradation are increased. As described above, the proteasome and autophagy were 
shown to work synergistically (Clague and Urbe 2010). Notably, as inhibition of the 
proteasome was shown to induce autophagic activity (Pandey, Nie et al. 2007) and vice 
versa (Zhu, Dunner et al. 2010), autophagy inhibition could lead to induced proteasome 
activity, which could bypass the lack of autophagic degradation. In conclusion, cell lines 
with extra chromosome show increased levels of p62, a receptor for selective autophagy. 
Why p62 is up-regulated and whether proteins from the extra chromosome are 
preferentially sequestered by p62 remains the subject of future research. The suggested 
role of p62 targeting over-expressed or malformed proteins may pinpoint to a function of 
p62 in sequestering excess protein encoded on the extra chromosome for degradation.  
 
To summarize, this study shows that aneuploid cell lines express mRNAs according to 
gene copy number, whereas some proteins encoded on the extra chromosome are 
compensated. These compensated proteins are mainly subunits of protein complexes as 
well as kinases. Compensation of subunits and kinases suggests that over-expression of 
these proteins may be harmful and compensation is required to maintain cellular 
physiology. In line, former studies proposed that protein imbalances of subunits and 
kinases are detrimental to the cellular homeostasis and that compensation of these 
proteins may be a common mechanism for deregulated proteins (Veitia, Bottani et al. 
2008). Moreover, 2-D pathway enrichment analysis revealed that cell lines with extra 
chromosomes display a common pattern of deregulated pathways when compared to 
their parental cell lines. This aneuploidy-response pattern was found in all analyzed cell 
lines, which shows that cellular physiology of aneuploid cells is not affected by the 
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specific set of over-expressed proteins according to the extra chromosome but rather by 
a common burden displayed in all aneuploid cells. The lysosomal pathway was up-
regulated in all cell lines, pinpointing towards a function of the lysosome in degrading 
excess protein. Testing for autophagy, a lysosomal degradation pathway revealed that 
p62 dependent autophagy is up-regulated in aneuploid cell lines, which implies a role of 
p62 in degrading excess protein in aneuploid cell lines. However, inhibiting autophagy did 
not lead to an accumulation of proteins encoded on the extra chromosome nor did the 
p62 knock down negatively affect the aneuploid cell line HCT116 5/4. p62 may also 
sequester proteins that are deregulated in aneuploids independently of proteins encoded 
on the extra chromosome. Aneuploid yeast cells, lacking the de-ubiquitinating enzyme 
Ubp6, displayed lower levels of proteins encoded on the disomic chromosome indicating 
that extra protein in yeast is degraded via the proteasome. In this study we only tested 
protein levels of proteasomal proteins and proteasome activity; however proteasomal 
degradation can also be modulated by other factors such as ubiquitin ligases. Therefore, 
we cannot exclude that proteasomal degradation plays a role in degrading excess 
proteins in human aneuploid cell lines and enhanced autophagic activity may be needed 
to compensate for the increased load of proteins on the proteasome. On the other hand, 
one may speculate that unfolded and non-incorporated subunit proteins might be prone 
to be aggregated. Furthermore, it was proposed that aggregated proteins may be rather 
degraded by autophagy as by the proteasome (Johansen and Lamark) providing an 
appealing model how protein compensation is achieved. Further research is needed to 
clarify the roles of autophagy and proteasome in aneuploid cells and may reveal 
interesting targets for aneuploidy based pathologies. 
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6 EXPERIMENTAL PROCEDURES  
 
6.1 Material 
Reagents and consumables not listed below were purchased from the listed companies: 
Abcam (Cambridge, UK), Beckman Coulter (Krefeld, Germany), Becton Dickinson 
(Heidelberg, Germany), Bio-Rad Laboratories (Munich, Germany), Cell Signaling 
Technologies (Frankfurt a. M., Germany), GE Healthcare (Munich, Germany), Invitrogen 
(Karlsruhe, Germany), Ibidi (Martinsried, Germany), Lonza (Basel, Switzerland), MBL 
(Woburn, USA), Merck Biosciences (Darmstadt, Germany), Nunc (Wiesbaden, 
Germany), Progen (Heidelberg, Germany), Promega (Madison, USA), QIAGEN (Hilden, 
Germany), R&D Systems (Minneapolis, USA), Roche (Mannheim, Germany), Roth 
(Karlsruhe, Germany), Santa Cruz Biotechnology (Heidelberg, Germany), Sarstedt 
(Nürmbrecht, Germany), SERVA Electrophoresis (Heidelberg, Germany), Sigma 
(Taufkirchen, Germany), TPP (Trasadingen, Switzerland), VWR (Darmstadt, Germany).  
Microbiological, molecular biological, cell biological and biochemical techniques were 
based on standard protocols (Sambrook et al., 1998) or conducted after manufacturer’s 
instructions. 
 
6.1.1 Chemicals, media and reagents  
4',6-diamidino-2-phenylindole     (DAPI, Roth) 
β-mercaptoethanol      (Merck) 
acetic acid       (Sigma-Aldrich) 
acrylamide (30% w/v)     (Serva) 
ammoniumpersulfate      (APS, Merck) 
bafilomycin A1      (Sigma-Aldrich) 
blasticidinS      (AppliChem) 
bromphenol blue      (Merck) 
bovine serum albumine (BSA)    (Sigma-Aldrich) 
colchicine       (Fluka) 
cytochalasin D      (Sigma-Aldrich) 
dimethylsulfoxide (DMSO)    (Serva) 
DMEM + GlutaMAXTM-I     (Invitrogen) 
ethanol       (Sigma-Aldrich) 
fetal bovine serum (FBS)    (Gibco) 
formaldehyde       (AppliChem) 
formamide       (Merck) 
G418       (Invitrogen) 
glycerol       (Sigma-Aldrich) 
HCl        (Merck) 
isopropanol       (Sigma-Aldrich) 
KCl        (Roth) 
 6 EXPERIMENTAL PROCEDURES  
78 
  
KH2PO4       (Merck) 
methanol       (Merck) 
MgCl2        (Merck) 
NaCl        (VWR) 
NaF        (Sigma) 
Na4HPO4       (Merck) 
Na4P2O7       (Sigma) 
N,N,N’-tertramethylethylene diamine (TEMED) (Serva) 
NP-40        (Sigma-Aldrich) 
Opti-MEM I + GlutaMAXTM-I     (Invitrogen) 
paint probes       (Chrombios) 
penicillin/ steptomycin (Pen-Strep, 100x)  (PAA) 
PlusTM Reagent      (Invitrogen) 
polyvinylidene fluoride membrane (PVDF)  (Roche) 
Protease inhibitor cocktail tablets   (Roche Diagnostics) 
sodium azide       (Merck) 
sodium dodecyl sulfate (SDS)    (Serva) 
Tris-(hydroxymethyl)-aminomethane (Tris)  (Sigma) 
trisodium citrate      (Sigma-Aldrich) 
Triton-X-100       (Roth) 
trypsin-EDTA (1x)      (PAA) 
tunicamycin       (Sigma-Aldrich) 
Tween 20       (Applichem) 
Vecta shield      (Vector Labs) 
L-arginine (Arg0),      (Sigma-Aldrich) 
L-lysine (Lys0),      (Sigma-Aldrich) 
L-13C615N4-arginine (Arg10)    (Sigma-Aldrich) 
L-13C615N2-lysine (Lys8)    (Sigma-Aldrich) 
dialyzed FCS      (Invitrogen) 
DMEM without arginine and lysine   (Invitrogen) 
 
6.1.2 Buffers 
Lämmli buffer      62.5 mM Tris/HCl pH 6.8 
2% (w/v) SDS 
10% (v/v) glycerol 
0.002% (w/v) bromphenole blue 
2.5% β- mercaptoethanol 
 
Lower running gel (15%), pH 8.8   7.5 ml 30% (w/v) acrylamide 
       3.75 ml lower SDS-buffer pH 8.8 
       3.75 ml H2O 
       150 µl APS 
       15 µl TEMED 
 
Lower SDS buffer, pH 8.8    1.5 M Tris/HCl 
       0.4% (w/v) SDS 
 
Lysis buffer (RIPA), pH 7.5    50 ml 10% NP-40 
5 ml 10% natriumdeoxycholate 
15 ml 5 M NaCl 
1 ml 0,5 M  EDTA 
25 ml 1 M Tris, pH 7,5 
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PBS(-T), pH 7.5     137 mM NaCl 
       2.7 mM KCl 
       10 mM Na4HPO4 
       2.0 mM KH2PO4 
       (0.1% Tween 20) 
 
Propidium iodide solution     69 µM propidium iodide  
100 µg/ml RNase  
in 38 mM sodium citrate 
 
SDS- running buffer     25 mM Tris/HCl 
200 mM glycine 
       0.1% (w/v) SDS 
 
20xSSC, pH 7.0     3 M sodium chloride 
       300 mM trisodium citrate 
 
Staining solution (ß-gal-assay)   5 mM K3Fe(CN)6,  
2 mM MgCl2,  
150 mM NaCl,  
30 mM citric acid/  
phosphate buffer 
5 mM K4Fe(CN)6, 
1 mg/ml X-Gal)  
 
TBS(-T)       50 mM Tris.HCl, pH 7.4 
150 mM NaCl 
(0.1% Tween 20) 
 
Transfer buffer     25 mM Tris/HCl 
1.44% (w/v) glycerol 
20% (v/v) methanol 
 
Upper SDS buffer, pH 6.8    0.5 M Tris/HCl 
       0.4% (w/v) SDS 
 
Upper stacking gel (7.5%), pH 6.8   1.25 ml 30% (w/v) acrylamide 
       1.25 ml upper SDS-buffer pH 6.8 
       2.5 ml H2O 
       50 µl APS 
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6.1.3 Plasmids and bacteria 
6.1.3.1 Plasmids 
pBOS-H2B-GFP      (BD Pharmingen) 
ptfLC3 plasmid (mRFG-GFP-LC3)     (Addgene) 
 
6.1.3.2 Bacteria 
XL-1 blue competent cells    (Stratagene) 
 
6.1.4 Kits 
ECLplus™ kit proteins     (GE Healthcare) 
GenElute™ HP Plasmid Maxiprep Kit   (Sigma-Aldrich) 
Gentra Puregene Kit      (Qiagen)  
Lipofectamin LTX and plus reagent    (Invitrogen) 
mRNeasy mini kit      (Qiagen) 
Plasmid mini kit      (Qiagen) 
Proteasome-Glo™ Chymotrypsin-Like   (Promega) 
Cell-Based Assay       
 
6.1.5 Technical equipment 
Electrophoresis Power Supply EPS 301  (GE Healthcare Biosciences, 
 USA)  
Eppendorf centrifuge 5415R, 5417 C  (Eppendorf, Germany) 
FACScalibur       (Becton Dickinson) 
Fluoroscan Ascent FL     (Labsystems, Australia)  
Hera Cell, Hera Safe, Megafuge 3.0R  (Thermo Fisher Scientific, 
 Germany) 
Mini-PROTEAN II electrophoresis system   (Bio-Rad Laboratories, Germany)  
MUPID ONE electrophoresis unit    (Advance Co., Japan)  
Nanodrop ND-1000 spectrophotometer   (PEQLAB, Germany)  
Rotina 420R centrifuge, Micro centrifuge SD220  (Hettich, Germany)  
SmartSpec 3000      (Biorad, Germany) 
Thermomixer comfort     (Eppendorf, Germany) 
Vortex Genie 2      (Scientific industries, USA)  
VWR Digital Heat Block     (VWR, Germany) 
X-ray film processor MI-5     (Medical Index, Germany)  
Z2 Coulter Particle Count and Size Analyzer  (Beckman Coulter, Germany). 
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6.1.5.1 Microscopy 
Confocal spinning disc microscope 
Confocal microscopy was performed using a fully automated Zeiss inverted microscope 
(AxioObserver Z1) equipped with a MS-2000 stage (Applied Scientific Instrumentation, 
Eugene, OR), the CSU-X1 spinning disk confocal head (Yokogawa), LaserStack Launch 
with selectable laser lines (Intelligent Imaging Innovations, Denver, CO) and an X-CITE 
Fluorescent Illumination System. Images were captured using a CoolSnap HQ camera 
(Roper Scientific) under the control of the Slidebook software (Intelligent Imaging 
Innovations, Denver, CO). 
Live cell imaging microscope 
Live cell imaging was performed using a Zeiss Axio Observer Z1 microscope equipped 
with a Plan Neofluar 20 × air objective. The microscope contains a sample stage with an 
incubator chamber (EMBLEM, Heidelberg, Germany) maintained at a 37° C, 40 % 
humidity, in an atmosphere of 5 % CO2. Metamorph 7.1 software (Molecular Devices) 
was used to control the microscope.  
 
6.1.6 Software 
Adobe Illustrator CS3 (13.0.0)  (Adobe Systems Incorporated, USA) 
Ascent software (2.6)    (Thermo Scientific) 
CellProfiler (2.0)    (BROAD Institute) 
Cell Quest Pro 5.2.1     (BD Bio Sciences)  
FlowJo 7.6.1     (Tree Star, Inc.)  
GraphPad Prism 5     (GraphPad Software, La Jolla, USA) 
Metamorph 7.1     (Molecular Devices, Germany) 
Slidebook 5.0      (Intelligent Imaging Innovations, USA) 
 
6.1.7 Antibodies 
6.1.7.1 Primary antibodies 
anti-LC3 (115-3)       (Medical & Biological  
Laboratories) 
anti-p62 (610832) (for immunoblotting)    (BD Transduction  
Laboratories) 
anti-p62 (GP62-C) (for immunofluorescence)   (Progen) 
anti-Ubiquitin (P4D1)       (Santa Cruz)  
anti-ß-Tubulin (ab21057)      (Abcam) 
anti-GAPDH (ab9483)      (Abcam)  
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6.1.7.2 Secondary antibodies  
goat anti-mouse IgG HRP affinity purified PAb (HAF007)  (R&D systems, US) 
donkey anti-goat IgG HRP affinity purified PAb (HAF109)  (R&D systems, US)  
anti-mouse FITC       (Abcam)  
anti-guinea pig dylight 649 (Jackson 
ImmunoResearch)  
anti-mouse dylight649 (Jackson 
ImmunoResearch) 
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6.2 Methods 
6.2.1 Cell culture  
6.2.1.1 Cell lines 
Cell lines HCT116 (ATCC No. CCL-247), HCT116 5/4 and HCT116 3/3 were a kind gift of 
M. Koi (Baylor University Medical Centre, USA). The cell line RPE-1 hTERT (hereafter 
referred to as RPE-1) and RPE-1 hTERT H2B-GFP (hereafter referred to as RPE-1 H2B-
GFP) were kindly provided by Stephen Taylor (University of Manchester, UK). Cell lines 
with extra chromosomes were created adding a chromosome by microcell fusion 
technique (see Experimental procedures, chapter: “microcell fusion technique”). As donor 
cell lines, mouse A9 cell lines were used containing the appropriate human chromosome 
which was purchased from the Health Science Research Resources Bank (HSRRB), 
Osaka 590-0535, Japan. HCT116 H2B-GFP was created by Christian Kuffer transfecting 
HCT116 with pBOS-H2B-GFP by lipofection (FugeneHD, Roche) according to 
manufacturer’s protocols.  
 
6.2.1.2 Cultivation  
Used cell lines were cultivated in Dulbecco´s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 100U penicillin and 100U 
streptomycin (pen-strep) at 37°C and 5% CO2 atmosphere. HCT116 3/3, HCT116 H2B-
GFP 5/3, HCT116 H2B-GFP 5/4, RPE1 5/3 12/3, RPE1 3/3, RPE1 H2B-GFP 21/3 and 
A9 cell lines were grown in medium with 400 µg/ml G418. The cell lines HCT116 5/4 and 
HCT116 with stable transfected H2B-GFP were grown in media with 6 µg/ml blasticidinS. 
BlasticidinS and G418 were omitted at least two passages before any experiment to 
avoid possible side effects on the experimental outcome.  
 
6.2.1.3 Sub-culturing and passaging 
Cell lines were grown in 10 or 15 cm cell culture dishes for 2-3 days at 37°C in a 5% CO2 
atmosphere to a confluency between 70 and 80%. Then, cells were washed with 1x PBS, 
afterwards trypsin-EDTA was added to the cells and incubated for 5 min at 37°C in 5% 
CO2 atmosphere. Cells were then resuspended in DMEM supplemented with FCS and 
pen-strep as described for cultivation and splitted in ratios between 1/5 to 1/10 to a new 
10 or 15 cm cell culture dish. The appropriate amount of fresh medium was added to the 
cells (a total of 10 ml for 10 cm dish and 20 ml for 15 cm dish). As observed during this 
study, cells with extra chromosome are less chromosomal stable as their parental cell 
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lines. Therefore, cells used for experiments did not exceed passage 15 after 
cryopreservation of cell lines generated by microcell fusion.  
 
6.2.1.4 Cryopreservation and recultivation 
Cells were grown as described to a confluency of 70-80%. Then cells were collected by 
trypsinization as mentioned above and carefully centrifuged at 1500 rpm for 3 min. The 
supernatant was removed and cells were resuspended in FCS/10% DMSO.  0.5-1 ml of 
suspension was added to cryotubes and frozen at -80°C using a freezing chamber filled 
with isopropanol. For long time storage, cells were placed in liquid nitrogen. To 
recultivate cells from frozen stocks, filled and frozen cryotubes were thawn in a 37°C 
water bath and cell suspension was pipetted into 10 ml of fresh and 37°C warm cell 
culture medium. After careful centrifugation at 1500 rpm for three minutes, cellpellets 
were again resuspended in appropriate amounts of suitable cellculture medium and 
seeded on a cell culture dish. 
 
6.2.1.5 siRNA transfection using Oligofectamine 
Cells were seeded one day before transfection on a 6 well plate. At the day of 
transfection, cells were between 50-60% confluent. At the day of transfection media was 
exchanged to 4 ml DMEM without FCS and antibiotics. At least two hours later, 8 µl 
siRNA (100 pmol/µl) and 175 µl OptiMEM were combined as well as 5 µl Oligofectamine 
was added to 15 µl OptiMEM. After 20 min both liquids were mixed and incubated for 5 
min at room temperature. Then mixture was added to the cells and cells were incubated 
till further processing. 
 
6.2.2 Molecular biology standard techniques 
6.2.2.1 Agarose gel electrophoresis  
Quality of genomic DNA was evaluated first by measuring 260/280 nm ratio using the 
Nanodrop ND-1000 and second by applying the gelelectrophoresis technique. Therefore, 
5 µl of genomic DNA was mixed with 1 µl of electrophoresis running dye and loaded on a 
1% agarose gel in TBS-T. The gel was run in a MUPID ONE electrophoresis unit at 100V 
for 20 min. Only high quality genomic DNA was used for arrayCGH analysis.  
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6.2.2.2 Bacteria transformation 
Competent XL-1 blue cells were thawn on ice and aliquoted at 50 µl into 1.5 ml 
eppendorf tubes. 1-5 µl plasmid DNA was added to the cells and mixed gently. Tubes 
were incubated on ice for 30 min. Then, cells were heat shocked at 42°C for 30 sec. 
Afterwards, tubes were placed on ice for two minutes and then 250 µl of pre-warmed LB 
medium was added. Samples were shaken at 37°C for one hour and 100 µl of each 
transformation was spread onto LB plates with appropriate antibiotics. Plates were then 
incubated overnight. Single colonies were used to create overnight cultures in 500 ml LB 
media plus appropriate antibiotics for plasmid extraction by maxi prep.  
 
6.2.2.3 Cell lysis 
Cells were grown to 70-80% confluency, collected by trypsinization and afterwards 
pelleted by centrifugation. Supernatant was removed and cells were lysed in appropriate 
amounts of RIPA buffer supplemented with a Protease inhibitor cocktail tablet (Roche) 
(one tablet/10 ml of buffer).  
 
6.2.2.4 Bio-Rad protein assay 
Bio-Rad Protein assay was conducted as described in the manufacturer’s protocol. In 
brief, Bio-Rad solution was diluted 1:5. To 1 µl of lysed cells resuspended in RIPA buffer 
999 µl of diluted BioRad solution was added. As blank 1 µl pure RIPA buffer was added 
to 999 µl of diluted BioRad solution. Samples were added to plastic cuvettes and 
absorbance at 595 nm was measured using the spectrophotometer SmartSpec 3000. 
Samples were measured in triplicates. Protein concentration was evaluated by 
comparing gained values to a standard curve previously generated using the same assay 
with known concentrations of BSA in solution.  
 
6.2.2.5 SDS-polyacrylamide gel electrophoresis (PAGE) 
After the protein concentration was evaluated by Bio-Rad protein assay, 20-50 µg of 
protein was mixed with 6x Lämmli-buffer and loaded on an appropriate, self-made SDS-
polyacrylamide gel.  Gel was run using the Mini-PROTEAN II electrophoresis system at 
200V for 45 min using SDS-running buffer. 
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6.2.2.6 Immunoblot  
After SDS-PAGE, the separated proteins were transferred to a methanol soaked PVDF 
membrane at 100V for one hour using the Mini-PROTEAN II electrophoresis system.  
The membrane was blocked in either 5% skimmed milk in TBS-T or 1% BSA in PBS-T 
(for LC3 and p62 antibodies). Primary antibodies were incubated at 4°C overnight 
whereas secondary antibodies were incubated at room temperature for one hour. Buffers 
used for antibodies were applied as described in the manufacturer’s protocols. As 
secondary antibody HRP-conjugates antibodies were used in a 1:5000 dilution. To 
visualize stained proteins, the ECLplus™ reagent was applied to the membrane as 
described in the manufacturer’s instructions. An Amersham hyperfilm ECL was incubated 
on the membrane using various, appropriate time points and developed using the X-ray 
film processor MI-5.  
 
6.2.3 Generation and characterization of cell lines 
6.2.3.1 Microcell fusion technique 
To generate aneuploid cell lines with, microcell fusion technique was performed as 
described (Fournier 1981). Therefore, Mouse A9 cells that contain in addition to their 
mouse chromosome content one human chromosome with an antibiotic resistance gene 
were used as donor cells. To induce mitotic slippage cells were treated for 48 h with 
colchicine (final concentration: 60 ng/ml). Then, cells were collected by trypsinisation and 
applied on plastic bullets. After attachment of the cells, bullets were centrifuged at 30-
34°C and 15000 rpm for 30 min in DMEM containing 10 µg/ml cytochalasin B. Pellets 
were resuspended in serum free DMEM and later on filtered using first Whatman, pore 
size 8 µm and later 5 µm to remove mouse cells from the suspension. 
Phytohemagglutinin (PHA-P) was applied to the mouse cells and applied to the recipient 
cell lines (HCT116 H2B-GFP, RPE1 or RPE1 H2B-GFP). Then, polyethylene glycol 1500 
(PEG 1500) was added to induce fusion of microcells with the recipient cells. Using 
medium supplemented with corresponding antibiotics enabled selection of cells 
containing the added chromosome. The cell line RPE1 5/3 12/3 contains an extra 
chromosome 12, which was not intentionally added to the cell line. This chromosome 
may be added to the recipient cell by chromosome missegregation before fusion.  
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Fig. 34: Generating aneuploid cells by microcell fusion technique. After colchicine treatment of Donor cell 
lines for 48 h micronuclei containing the extra human chromosome were extracted and fused to recipient cells. As 
recipient cells HCT116 and RPE-1 cell lines were used. Cell lines were selected by adding the appropriate 
antibiotics. (Figure adapted from: (Killary and Lott)). 
 
 
6.2.3.2 Chromosome spreads 
Cells were cultivated as described. After reaching 70-80% confluency, cells were treated 
with 50 ng/ml colchicine for 3-5 h. Then, cells were collected by trypsinization and 
centrifuged for 10 min at 1000 rpm. Cell pellets were carefully resuspended in 75 mM KCl 
and kept at 37°C for 10-15 min. Carefully at 800 rpm for 10 min centrifuged cell pellets 
were fixed in 3:1 methanol/acetic acid after removing most but leaving some remaining 
supernatant. After washing the cell pellets several times with 3:1 methanol/acetic acid, 
dead and swollen cells were spread on a wet glass slide that was later air dried at 42° C 
for 5 min.  
 
6.2.3.3 Paints 
Chromosome spreads were carried out as described. Then, chromosomes spreads were 
labeled with paints probes (Chrombios GmbH, Raubling, Germany) for chromosome 2, 3, 
5 and 21 tagged with TAMRA, FITC, Cy-5 and TAMRA, respectively. Cell lines were 
always stained with two probes. One probe that stained the expected added 
chromosome and one probe that stained a control chromosome that was not added to 
the cells. The experimental procedure was carried out according to the manufacturer’s 
instructions. Before imaging, chromosomes were counterstained with DAPI. Images were 
taken by the confocal spinning disc microscope using a 100x oil objective and the 
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appropriate laser (561 nm (TAMRA), 473 nm (FITC) or 660 nm (Cy-5) laser). The DAPI 
signal was detected using the UV channel.  
 
6.2.3.4 Multiplex FISH (M-FISH) 
Chromosome spreads were prepared as described above. M-FISH analysis was 
performed by Chrombios GmbH (Raubling, Germany) 
 
6.2.4 Growth and Cell Cycle Studies 
6.2.4.1 Growth curves 
Cells that reached 70-80% confluency were trypsinized and counted in triplicates either 
by haemocytometer or by a Beckman Coulter Particle Count and Size Analyzer Z2. After 
seeding exactly 300000 cells in each well of a six well plate time points were taken for 5 
days every day. Cells were counted as described. The experiment was performed in 
triplicates. The mean values were taken to generate the growth curves. The error bars 
indicate the standard deviation. Cell lines with extra chromosome were always compared 
to their parental cell lines that were cultivated in parallel.  
 
6.2.4.2 Cell death analysis 
Cells were trypsinized after three days, reaching a confluency of 70-80% and 
resuspended in DMEM/10% FCS/1% pen-strep. After collection cells were kept on ice 
throughout the whole experimental procedure and propidium iodide was added (final 
concentration: 69 µM). Incorporated propidium iodide was measured in the FL-3 channel 
by FACS using the FACScalibur (Becton Dickinson) operated by the Cell Quest Pro 
software. Later analysis was performed by using the FlowJo software. The experiment 
was performed in triplicates. The mean values are depicted; error bars represent 
standard error of mean. 
 
6.2.4.3 ß-galactosidase assay 
Cells were grown in a 6 well plate dish until reaching 70-90% confluency. After washing 
the cells three times with PBS, 3% formaldehyde/1x PBS was added for fixation. To 
remove the formaldehyde, cells were again washed twice with 1x PBS. Staining solution 
was applied for two hours at 37°C and images were taken using 20x bright field (spinning 
disc microscope). ß-galactosidase positive and negative cells were counted. The 
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experiment was performed in triplicates. The mean value is displayed in the graph, the 
error bars indicate the standard error of mean. As a positive control cells were treated 
with 0.2 µM doxorubicin for 7 days. Most cells treated with doxorubicin were ß-
galactosidase positive. 
 
6.2.4.4 DNA content measurements using fluorescence activated cell sorting 
(FACS)  
Cells were grown for three days after splitting in a 10 cm dish to 70-80% confluence and 
collected by trypsination. After gentle centrifugation cells were resuspended in 70% ice 
cold ethanol and fixed for 20 min. Afterwards, cells were centrifuged, then washed with 
1x PBS and finally resuspended in propidium iodide solution (69 µM propidium iodide and 
100 µg/ml RNase in 38 mM sodium citrate). Samples were measured using the FL-2 or 
FL-3 channel by FACS analysis (FACScalibur (Becton Dickinson) controlled by the Cell 
Quest Pro software. FACS profiles were later evaluated by FlowJo software and graphs 
were generated using the Prism software. The experiment was conducted in triplicates. 
Cell lines with extra chromosome were always compared to their parental cell lines which 
were grown in parallel. All experiments were performed in three biological replicates; the 
error bars represent the standard error. Unpaired T-test was used to evaluate the 
statistical significance. 
 
6.2.4.5 Thymidine release 
For thymidine release experiment 1x106 cells were seeded on a 6 cm dish.  After 
attachment of the cells the medium was exchanged to medium containing 2 mM 
thymidine. After 30 h cells were released from the thymidine block by washing 3x with 
PBS. Cell culture medium was added and cells were incubated at 37°C and 5% CO2. For 
the time course samples were taken every hour. Samples were measured as described 
for the DNA content measurement by FACS. Gained profiles were later evaluated by 
fitting the curve to the Watson model included in the FlowJo software. As a parameter to 
calculate the length of each phase, the distance between the time where 50% of the cells 
reach the corresponding DNA content was calculated.  
 
6.2.4.6 Live cell imaging 
HCT116 H2B-GFP and HCT116 H2B-GFP 5/4 cell lines were seeded sparsely on a 6 
channel µ-slide (Ibidi, Martinsried, Germany). 24 h after seeding time laps imaging was 
started in a 10 min (for time in interphase) or 4 min (for time in mitosis) interval for 72 or 
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48 h, respectively. Therefore, the slide was placed onto the sample stage of the live cell 
imaging microscope (using the incubator chamber maintained at a 37°C, 40% humidity, 
in an atmosphere of 5% CO2). Images were taken by the 20× air objective. The 
microscope was controlled by Metamorph software. Later evaluation of images was 
conducted using the ImageJ software. Time in interphase was measured from first 
observed nuclear envelope breakdown (NEB) to the second observed NEB. Time in 
mitosis was measured from NEB to the onset of anaphase (OA). Experiment was carried 
out in biological triplicates. Graphs were generated with Prism. Mean values are 
indicated in the graph; error bars indicate the standard error of mean.  
 
6.2.5 Autophagy and proteasome studies 
6.2.5.1 Proteasome activity assay 
In parallel 2x104 trypsinized and washed HCT116, HCT116 3/3 and HCT116 5/4 were 
seeded in triplicates on a 96 well plate. 40 min later Proteasome-Glo™ Chymotrypsin-
Like Cell-Based Assay (Promega) was added according to manufacturer’s protocol.  
Luminescence was detected using a Fluoroskan Ascent FL plate reader operated by the 
Ascent software. Experiment was conducted three times. For evaluation the mean with 
SEM of the biological triplicates was calculated and depicted using Prism software. 
Unpaired T-test was used to calculate significances. 
 
6.2.5.2 Immunofluorescence experiments 
Cells were seeded on glass objectives or ibidi 8 well slides and cultivated for two days to 
50-70% confluency. Cells were washed with 1x PBS-T and fixed by 3.7% 
paraformaldehyde. Fixed cells were washed twice with PBS and permeabilized with 0.5% 
Triton X-100 in PBS. Then cells were blocked in 2% BSA in PBS-T and afterwards 
stained with anti-LC3 (1:100), anti-p62 (1:100) or anti-ubiquitin (1:50) antibodies. After 
staining with primary antibody cells were again washed three times with 1x PBS-T. The 
fluorescent secondary antibodies: anti-mouse dylight649, anti-guinea pig dylight649, anti-
mouse FITC and anti-guinea pig dylight649 were applied (1:1000) for one hour at room 
temperature. Cells were washed three times with PBS-T, counterstained with 50 ng/ml 
DAPI in PBS-T and washed once with PBS-T. If glass objectives were used objective 
was mounted on glass slides using Vecta shield. Cells seeded on ibidi slides were 
imaged through PBS-T supplemented with sodium azide (0.1%) to avoid bacterial 
growth. For amplification of the signal autophagy of some cells was additionally inhibited 
to allow accumulation of p62 and ubiquitin. Therefore, cells were treated for 16-18 hours 
before fixation with 50 nM bafilomycin A1. 
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For LC3 immunofluorescence intensity analysis images were analyzed using the 
Slidebook software. The background of each image was identified and subtracted. To 
allow comparison levels were adjusted equally for all analyzed samples. Cells were 
marked as objects and then fluorescence mean intensity of the identified objects were 
used for evaluation. Graph was generated using the Prism software. Mean with SEM is 
shown in the graph. Significance was calculated by unpaired T-test.  
To evaluate the p62 mean intensity/cell the cell profiler software was used. Therefore, the 
cell cytoplasm was additionally stained by HCS cell mask red dye (Invitrogen) before 
fixation to allow proper automated cell segmentation. Then, the mean intensity of p62/cell 
was analyzed automated by the software. Given values were plotted by using the Prism 
software. Mean is depicted in the graph, error bars indicate the SD. Unpaired T-test was 
conducted to test for significance. 
To evaluate p62 and ubiquitin co-localization cells were stained with p62 and anti-
ubiquitin. To compare images, the background was subtracted and fluorescence intensity 
levels were adjusted equally for each image. Line intensities were evaluated using the 
“line intensity” tool of the Slidebook software. To allow in parallel comparison of ubiquitin 
and p62 signal, the ubiquitin signal intensity of all images was multiplied by the factor 40 
since ubiquitin signals were in general low.   
 
6.2.5.3 Autophagy flux assay 
HCT116, HCT116 3/3 and HCT116 5/4 cell lines were seeded one day before 
transfection and grown to 40% confluency. Then, the ptfLC3 plasmid (mRFG-GFP-LC3,) 
was transfected using Lipofectamin LTX and plus reagent as described before. Cells 
were fixed two days later when mRFP-GFP-LC3 was fully expressed and images were 
taken by spinning disc microscopy. Images were taken by 100x oil objective applying the 
561 nm (mRFP) and 473 nm (GFP) lasers. Due to transient transfection levels differ in 
every cell. Therefore, fluorescence levels of cells were individually adjusted.  
 
6.2.5.4 Evaluation of cell survival after autophagy inhibition  
HCT116-derived cell lines were seeded the day before the experiment on a 96 well plate. 
Shortly, before the experiment was started cells were treated with the autophagy 
inhibiting drugs bafilomycin and chloroquine to test if aneuploid cell lines are more 
sensitive towards the drugs than their disomic counterparts. To all cells treated with 
bafilomycin a concentration of 5 nM was applied. Chloroquine was added in a 
concentration of 10 µM for HCT116 H2B-GFP and HCT116 H2B-GFP 5/4 and 50 µM for 
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HCT116, HCT116 5/4 and HCT116 3/3, as a 10 µM concentration was too low for cell 
death studies. After treatment, the 96 well plate was mounted on the live cell imaging 
microscope. Time laps imaging was started imaging in bright field in a 10 min interval for 
at least 52 h. Then, movies were evaluated by Slidebook software, monitoring the time of 
cell death. Survival curves were generated by Excel software. 
 
6.2.5.4 Evaluation of time in interphase after p62 knockdown 
HCT116-derived cell lines were seeded three days before the experiment on a 6 well 
plate. One day later, when cells were around 30-50% confluent they were transfected 
with p62 and scrambled siRNA by Oligofectamin as described above. Then, one day 
later, cells were seeded on a 6 well plate for western blot analysis and on an 8 well ibidi 
slide for live cell imaging. One day after seeding, cells for western blot were collected and 
lysed and 8 well ibidi slide was mounted on the live cell imaging microscope for time 
lapse imaging in a humidified 37°C chamber in 10 min intervals. Movies were evaluated 
using the slidebook software. Cells were tracked and time in interphase was evaluated by 
monitoring the time from the first observed nuclear envelope breakdown (NEB) to the 
second NEB. Data was evaluated by the Prism software. An unpaired T-test was 
performed to evaluate significances. Time in interphase of cells with p62 knockdown was 
not significantly altered compared to cells treated with scrumbled siRNA. 
 
6.2.6 Experimental setup for genome, transcriptome and proteome analysis  
6.2.6.1 Array comparative genomic hybridization (CGH) 
Genomic DNA (gDNA) for arrayCGH (aGCH) analysis was extracted from 70-80% 
confluent cells after trypsinization and pelleting using the Qiagen Gentra Puregene Kit 
following manufacturer’s instructions. gDNA quality and quantity was measured by DNA 
absorbance and 260nm/280nm ratio measured by NanoDrop spectral photometer. gDNA 
quality was also tested on a 1.0% agarose gel stained with ethidium bromide. 1 µg of 
gDNA was used for each aCGH analysis.  The genomic DNA was sent to IMGM 
laboratories, Martinsried, Germany, who performed the aCGH experiment. As a 
reference sample commercially available human gDNA (Promega) was used for all 
4x44K array based analyses (conducted with gDNA extracted from HCT116, HCT116 
3/3, HCT116 5/4, HCT116 H2B-GFP 5/3, HCT116 H2B-GFP 5/4). aCGH analysis from 
gDNA of the cell line RPE1 H2B-GFP 21/3 was carried out by SurePrint 4x180K G3 
Human CGH Microarray. gDNA of HCT116 and HCT116 5/4 cell lines were used for the 
high density CGH analysis in direct comparison using the 2x400K array.  
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6.2.6.2 mRNA array 
mRNA was extracted from 70-80% confluent cells after trypsinization and pelleting using 
the Qiagen mRNeasy mini kit. mRNA array analysis was performed in biological 
triplicates. mRNA array was carried out by IMGM laboratories. mRNA quality and 
quantity was identified by NanoDrop spectral photometer. mRNA quality was also tested 
on an 1.0% agarose gel stained with ethidium bromide. 500 ng of total RNA was used for 
the experiment according to IMGM laboratories standard protocol. Agilent Whole Human 
Genome Oligo Microarrays (4x44K format) were used for experiments in combination 
with a One-Color based hybridization protocol. Microarray signals were detected using 
the Agilent DNA Microarray Scanner. Finally, raw data was quantile normalized. 
 
6.2.6.3 SILAC labeling 
DMEM lacking arginine and lysine with 10% dialyzed FBS with a cutoff of 10 kDa and 1% 
pen-strep was used as a basis medium. For labeling, arginine and lysine were added 
either as light (Arg0; Lys0) or as heavy (Arg10; Lys8) isotope (final concentration: 33.6 
µg/ml for arginine and 73 µg/ml for lysine). RPE1 and HCT116 cells were grown in heavy 
(Arg10; Lys8) SILAC medium for 8 to 10 passages. Aneuploid cell lines were grown for 3-
4 passages in light (Arg0; Lys0) medium. For the SILAC analysis after autophagy 
inhibition (description see below) a SuperSILAC mix experiment was conducted labeling 
HCT116 treated and untreated with bafilomycin with light, medium (Arg6 and LysD4) and 
heavy isotopes.  
HCT116, HCT116 5/4, HCT116 H2B-GFP 5/4, HCT116 H2B-GFP 5/3, HCT116 3/3 and 
all RPE-1 derived cell lines were conducted as double labeling experiments. HCT116 and 
HCT116 5/4 labeling was performed in biological triplicates including 6 measurements 
with one of them as label switch experiment, to exclude that observed phenotypes are 
due to labeling side effects. SILAC experiments with RPE-1 derived cell lines were also 
conducted as biological triplicates.    
 
6.2.6.4 SILAC analysis after autophagy inhibition 
Cells were labeled for 7 passages in light, medium and heavy SILAC medium. 30 h 
before cell collection 10 nM bafilomycin was added to inhibit autophagy. Treated as well 
as untreated HCT116 and HCT116 5/4 cell lines were labeled in light, medium and heavy 
medium. Then, a SuperSILAC mix (Geiger, Cox et al. 2010) was generated by mixing all 
medium labeled conditions. Then, equal protein amounts of the SuperSILAC mix 
(medium label), the untreated cells and the treated cells were mixed. To compare all 
conditions directly with each other, the SuperSILAC mix serves as an internal standard.      
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6.2.6.5 Sample processing for SILAC experiments 
Labeled cells were collected by trypsinization and washed twice with PBS. After 
collection cells were kept on ice. After washing cell pellet was stored at -80°C. Sample 
processing after collection and data analysis of Mass spectrometry data was conducted 
by Gabriele Stoehr. For detailed information see experimental procedures of this 
published data (Stingele, Stoehr et al. 2012).  
 
6.2.7 Analysis of genome, transcriptome and proteome data 
Processing of DNA, mRNA and protein raw data as well as generation of 2-D 
annotations, boxplots of categories and density distribution graphs were performed by 
Gabriele Stoehr.  
 
6.2.7.1 Analysis of CGH data  
To subtract the background the raw values of CGH signal (“r BGSubSignal”) from 
HCT116 and cell lines with extra chromosome were divided by their control background 
signal (“g BGSubSignal”). Then, ratios of ratios between the signal of cell lines with extra 
chromosome and their corresponding parental cell line were calculated. These values 
were afterwards converted into log2 ratios. The median of the whole population was 
subtracted to allow centering around zero.  
 
6.2.7.2 Analysis of the mRNA data  
mRNA array analysis were performed in biological triplicates. Ratios were transformed in 
log2 values and then the triplicates were averaged using their median. The value of 
HCT116 was subtracted from the values of HCT116 5/4.  
 
6.2.7.3 Analysis of protein data 
First, the protein list output file was filtered for contaminants and reverse entries. Ratios 
were transformed in log2 values. For technical replicates median values were calculated. 
Then, median ratios for the biological replicas of the HCT116 5/4 experiments were 
calculated. Only median ratios derived from at least two biological replicas were taken for 
further analyses. For the other cell lines with extra chromosome, normalized protein 
ratios were used. SuperSILAC HCT116 and bafilomycin treated samples were filtered as 
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described for HCT116 5/4. Median ratios obtained based on the SuperSILAC mix were 
calculated and used for further analyses.  
 
6.2.7.4 Combination of the pre-processed DNA, mRNA and protein results 
All described CGH and mRNA log2 entries were matched to their corresponding protein 
entries (median values). CGH data and protein data were combined by their 
chromosomal location (position information from Ensembl  
(http:/www.ensembl.org/index.html). mRNA and protein data were combined using 
specific “Probe set” names and their corresponding Uniprot entries. Cell line HCT116 5/4 
contains parts of chromosome 5 at level as expected for diploid cell lines. These parts 
were removed from the analysis. Therefore, thresholds to remove data from analysis 
were set at 0.65 and 0.6 for HCT116 5/4 and HCT116 H2B-GFP 5/4. 
 
6.2.7.5 Two-dimensional (2-D) annotation analysis  
Significant regulations of categorical annotations between two different cell lines were 
analyzed using a 2-D annotation distribution analysis (Geiger, Cox et al. 2010). For 
analysis, Gene Ontology (GO) biological processes (GOBP), molecular functions 
(GOMF) and cellular components (GOCC), KEGG pathways, proteins within complexes 
(CORUM) and chromosomes have been taken into account. To test, whether the 
expression of proteins of a given category is significantly different from the remaining 
population a non-parametric two-sided Wilcoxon-Mann-Whitney test was applied, using 
Benjamini-Hochberg false discovery rate (threshold 2%) for multiple hypothesis testing. 
The algorithm calculates relative regulation values between -1 and 1 for each significant 
category.  
 
6.2.7.6 Density histograms for different populations 
Density histograms were generated by using the R software. Interesting populations were 
plotted in one figure using the density function. Median ratios of the subpopulation and 
numbers of the populations are depicted within the plots. Proteins that are a subunit of a 
complex were extracted applying the CORUM database (http://mips.helmholtz-
muenchen.de/genre/proj/corum/). The subpopulation Kinase Activity was extracted from 
the GOMF terms (entries: “kinase activity”). Relative protein abundance of single proteins 
is depicted below the graph with black vertical lines. 
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6.2.7.7 Detailed analysis of kinases and complexes  
Complex proteins as well as proteins with kinase activity from the HCT116 5/4 data were 
extracted as described above. 
For complex analysis, complexes that contain at least one protein and corresponding 
mRNA and DNA entries coded on the tetrasomic chromosome 5 were analyzed. 
Depicted are all analyzed complexes with at least 5 total protein entries of subunits.  
To compare all kinases encoded on chromosome 5, all DNA, mRNA and kinase entries 
that are present in 4 DNA copies were plotted. Scatter plots of DNA, mRNA and proteins 
were generated by the Prism Software. Medians with their interquartile range were 
calculated by the Prism software. 
 
6.2.7.8 Boxplot analysis 
For boxplot analysis the category GOBP autophagy or KEGG proteasome were extracted 
from dataset. Then, the ratios between different cell lines with extra chromosome were 
compared by using the geom_boxplot function from the R package ggplot2. The median 
of the population is depicted as black line. The 25% and 75% quantiles are depicted in 
the graph.   
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8 ABBREVIATIONS 
 
2-D    two-dimensional 
µ    micro 
aa    amino acid 
aCGH    array-comparative genomic hybridization 
ADP    adenosine 5’-diphosphate 
AML    acute myeloid leukaemia 
AMP    adenosine 5’-monophosphate 
APS    ammonium-peroxo-disulfate 
Arg    arginine 
ATG    autophagy related genes 
ATP    adenosine 5’-triphosphte 
β-Gal    beta-galactosidase 
bp    base pairs 
β-ME    beta-mercaptoethanol 
BSA    bovine serum albumin 
C    DNA content 
C-terminal   carboxyterminal 
°C    degree Celsius 
C. elegans   Caenorhabditis elegans 
chr.     chromosome 
CIN    chromosomal instability 
CORUM   KEGG pathways, molecular complexes 
DMEM    Dulbecco’s modified Eagle medium 
DMSO    dimethylsulfoxide 
DNA    deoxyribonucleic acid 
DTT    dithiothreitol 
DUB    de-ubiquitinating enzyme 
E1    ubiquitin activation enzyme 
E2    ubiquitin conjugating enzyme   
E3    ubiquitin ligase 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
e.g.    exempli gratia, for example 
ER    endoplasmic reticulum 
ERAD    endoplasmic-reticulum-associated protein degradation 
ESR    environmental stress response 
FACS    fluorescence-activated cell sorting 
FBS    fetal bovine serum 
Fig.     Figure 
FISH    fluorescence in situ hybridization 
g    gram; gravitational constant 
G1 phase   gap 1 phase of the cell cycle 
G2 phase   gap 2 phase of the cell cycle 
G418    geneticine disulfate 
GCR    gross chromosomal rearrangements 
gDNA    genomic DNA 
GFP    green fluorescent protein 
GO    gene ontology 
GOBP    GO biological processes 
GOCC    GO cellular components 
GOMF    GO molecular functions 
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h    hour(s) 
H    histone 
γH2AX    phosphorylated histone 2A variant X 
H2B    histone 2B 
HCT116 3/3   cell line HCT116 plus one chr. 3 
HCT116 5/4   cell line HCT116 plus two chr. 5 
HCT116 H2B-GFP 5/3 cell line HCT116 H2B-GFP plus one chr. 5 
HCT116 H2B-GFP 5/4 cell line HCT116 H2B-GFP plus two chr. 5 
HSFs    heat shock transcription factors 
HSPs    heat shock proteins 
HU    hydroxyurea 
hTERT    human telomerase reverse transcriptase 
IP    immunoprecipitation 
K    lysine, kilo (for aCGH) 
k    kilo 
kb    kilo base pairs 
kDa    kilo Daltons 
KEGG    Kyoto Encyclopedia of Gene and Genomes 
l    liter 
LB-media   Luria-Bertani media 
LIR    LC3 interacting region 
Lys    lysine 
m    mili 
M    molar 
M-FISH   Multiplex-FISH 
MIN    microsatellite instability 
min    minute(s) 
MEF    mouse embryonic fibroblasts 
mRFP    monomeric red fluorescent protein  
mRNA    messenger RNA 
MSL    male-specific lethal 
MW    molecular weight 
N    chromosome content   
n    nano 
NEB    nuclear envelope breakdown 
OA    onset of anaphase 
OD    optical density 
p    pico 
PB1    Phox and Bem1p 
PHA-P    phytohemagglutinin  
PI    propidium iodide   
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate-buffered saline 
PE    phosphatidyl ethanolamine 
PEG    polyethylene glycol 
PVDF    polyvinylidenfluorid  
RNase    ribonuclease 
ROS    reactive oxygen species 
RPE-1    cell line RPE-1 hTERT 
RPE-1 5/3 12/3  RPE-1 cell line plus one chr. 5 and one chr. 12 
RPE-1 H2B-GFP 21/3 RPE-1 H2B-GFP cell line plus one long arm of chr. 21 
rpm    rounds per minute 
s    seconds 
S    sedimentation coefficient (Svedberg) 
SAC    spindle assembly checkpoint 
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SCNAs   small site specific changes 
SD    standard deviation 
SDS    sodium dodecylsulfate 
SEM    standard error of mean 
SILAC    stable isotope labeling of amino acids in cell culture 
TBS    tris-buffered saline 
TEMED   N,N,N´,N´- tetramethylethylene diamine 
Tris    tris (hydromethyl) aminomethane 
U    unit 
UBA    ubiquitin associated 
UPR    unfolded protein response 
UPS    ubiquitin proteasome system 
UV    ultra violet 
V    volt 
v/v    volume per volume 
w/v    weight per volume 
X    times 
X-Gal    5-bromo-4-chloro-indolyl-β-D-galactopyranoside 
YAC    yeast artificial chromosome 
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